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I N T R O D U C T I O N
The -aminobutyric acid (GABA) transporter, GAT1, is 
widely expressed in the mammalian brain. It was the 
first identified gene in the solute carrier 6 (SLC6) gene 
family (Guastella et al., 1990), which also includes trans-
porters for dopamine, serotonin, norepinephrine, and 
glycine. This family is characterized by an absolute re-
quirement for Na
+ cotransport, which provides part of 
the  driving  force  to  accumulate  neurotransmitter 
against an otherwise unfavorable concentration gradi-
ent. Transporters in this family also exhibit a variable 
and incompletely understood necessity for Cl
 cotransport 
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receptor; NFRET, normalized FRET; PDZ, postsynaptic density 95/discs 
large/zona occludens 1; ROI, region of interest; SLC6, solute carrier 6;   
SV40, simian virus 40; TM, transmembrane domain; XFP, cyan or yellow 
fluorescent proteins, collectively; YFP, yellow fluorescent protein.
in the transport process (Lester et al., 1996; Rudnick, 
2002; Kanner, 2006; Reith et al., 2006).
In the healthy brain, density and surface/cytoplasm 
distribution of GAT1 transporters are tightly regulated. 
Previously, we determined that presynaptic boutons and 
axons have GAT1 molecules at a surface density of 800–
1,300 µm
2, with 61–63% of these molecules expressed 
on the plasma membrane (Chiu et al., 2002). This pool 
of  transporters  cycles  to  and  from  the  plasma  mem-
brane, a process that plays a critical role in shaping neuro-
transmission and is both constitutively and functionally 
regulated (Whitworth and Quick, 2001; Zahniser and 
Doolen, 2001; Deken et al., 2003; Loder and Melikian, 
2003; McHugh et al., 2004; Holton et al., 2005; Wang 
and Quick, 2005; Quick, 2006; Boudanova et al., 2008).
Although SLC6 transporters do function to some ex-
tent when expressed as monomers (Scholze et al., 2002; 
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The mouse -aminobutyric acid (GABA) transporter mGAT1 was expressed in neuroblastoma 2a cells. 19 mGAT1 
designs incorporating fluorescent proteins were functionally characterized by [
3H]GABA uptake in assays that re-
sponded to several experimental variables, including the mutations and pharmacological manipulation of the cy-
toskeleton. Oligomerization and subsequent trafficking of mGAT1 were studied in several subcellular regions of 
live cells using localized fluorescence, acceptor photobleach Förster resonance energy transfer (FRET), and pixel-
by-pixel analysis of normalized FRET (NFRET) images. Nine constructs were functionally indistinguishable from 
wild-type mGAT1 and provided information about normal mGAT1 assembly and trafficking. The remainder had 
compromised [
3H]GABA uptake due to observable oligomerization and/or trafficking deficits; the data help to 
determine regions of mGAT1 sequence involved in these processes. Acceptor photobleach FRET detected mGAT1 
oligomerization, but richer information was obtained from analyzing the distribution of all-pixel NFRET ampli-
tudes. We also analyzed such distributions restricted to cellular subregions. Distributions were fit to either two or 
three Gaussian components. Two of the components, present for all mGAT1 constructs that oligomerized, may 
represent dimers and high-order oligomers (probably tetramers), respectively. Only wild-type functioning con-
structs displayed three components; the additional component apparently had the highest mean NFRET ampli-
tude. Near the cell periphery, wild-type functioning constructs displayed the highest NFRET. In this subregion, the 
highest NFRET component represented 30% of all pixels, similar to the percentage of mGAT1 from the acutely 
recycling pool resident in the plasma membrane in the basal state. Blocking the mGAT1 C terminus postsynaptic 
density 95/discs large/zona occludens 1 (PDZ)-interacting domain abolished the highest amplitude component 
from the NFRET distributions. Disrupting the actin cytoskeleton in cells expressing wild-type functioning trans-
porters moved the highest amplitude component from the cell periphery to perinuclear regions. Thus, pixel-by-
pixel NFRET analysis resolved three distinct forms of GAT1: dimers, high-order oligomers, and transporters 
associated via PDZ-mediated interactions with the actin cytoskeleton and/or with the exocyst.
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mercial–Share Alike–No Mirror Sites license for the first six months after the publication 
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transporter complexes, as also determined by functional 
[
3H]GABA uptake assays. Moreover, we find that the ra-
tio of the FRET between peripheral and perinuclear 
subcellular compartments correlates with each construct’s 
function. Furthermore, the all-pixel FRET amplitude 
distributions have up to three components with low, in-
termediate, and high mean amplitudes; these correspond 
to mGAT1 dimers, higher-order oligomers, and mGAT1 
PDZ-interaction domain–mediated events in specific sub-
cellular compartments, respectively.
M AT E R I A L S   A N D   M E T H O D S
Materials
pEYFP-C1 or pECFP-C1 vectors were purchased from Takara Bio 
Inc. PfuTurbo Cx Hotstart polymerase and the QuikChange II XL 
site-directed mutagenesis kit were purchased from Agilent Tech-
nologies. The mouse N2a (CCL-131) and the human embryonic 
kidney  T/17  cell  line  (HEK  293T;  CRL-11268)  were  obtained 
from American Type Culture Collection. The pcDNA3.1(+) ex-
pression vector, Dulbecco’s modified Eagle’s medium (DMEM) 
with 4 mM l-glutamine, OptiMEM 1, FBS, and Lipofectamine and 
PLUS reagents were purchased from Invitrogen. Penicillin/strep-
tomycin 100× and Na pyruvate 100× solutions were purchased 
from Mediatech, Inc. 35-mm culture dishes with 14-mm glass bot-
toms of #0 thickness were procured from MatTek. Other tissue 
culture plasticware was purchased from Greiner Bio-One. The 
bicinchoninic acid protein assay, EZ-Link Sulfo-NHS-Biotin, and 
immobilized monomeric avidin beads were obtained from Thermo 
Fisher Scientific. 4-amino-n-[2,3-
3H]butyric acid ([
3H]GABA; 87 
Ci/mmol)  and  ECL  Plus  Western  blotting  detection  reagents 
were obtained from GE Healthcare. Anti-GAT1 antibody AB1570W 
and goat anti–rabbit peroxidase–conjugated secondary antibody 
were  obtained  from  Millipore.  Anti–green  fluorescent  protein 
(GFP)  rabbit  antiserum  132002  was  obtained  from  Synaptic 
Systems GmbH. Protease inhibitor cocktail tablets were obtained 
from Roche. Scinti-Safe 30% liquid scintillation cocktail was pur-
chased from Thermo Fisher Scientific. The plasmids for 4YFP 
and/or 2CFP nicotinic acetylcholine receptors (nAChRs) can 
be obtained as Addgene plasmids 15245 and 15106 (http://www 
.addgene.org) and were described previously, together with the 
cDNAs for the nonfluorescent subunits from which they were 
constructed (Nashmi et al., 2003; Khakh et al., 2005). The ECFP-
GalT plasmid was obtained from Addgene (plasmid 11937) (Cole 
et al., 1996). Polyethyleneimine (PEI) 50% solution in H2O, 
GABA, latrunculin B, and all other reagents were purchased from 
Sigma-Aldrich.
Cell culture and transfections
N2a cells were cultured as described previously (Son et al., 2009). 
Cells were plated onto 12-well plates, 60-mm dishes, or 35-mm 
culture dishes with 14-mm glass bottoms that we precoated with 
0.05% PEI (pH 8.4 in borate buffer; 100 mM Na2B4O7, and   
100 mM H3BO3). HEK 293T cells were cultured at 37°C in 95% 
air, 5% CO2 in culture media composed of 88% DMEM, 10% FBS, 
100 IU/ml penicillin, 100 µg/ml streptomycin, and 1 mM Na py-
ruvate. Transfections were performed using a modification of the 
manufacturer’s  Lipofectamine  and  PLUS  reagent  protocol  to 
achieve expression levels of transporter that exceed neither the 
cells’ synthetic machinery nor trafficking mechanisms (supple-
mental Materials and methods and Table S1). Latrunculin B incu-
bations  were  performed  as  described  previously  (Imoukhuede   
et al., 2009).
Soragna et al., 2005), constitutive transporter oligomer-
ization is a major factor in the release of newly synthe-
sized  transporter  from  the  ER  (Scholze  et  al.,  2002; 
Sorkina et al., 2003; Torres et al., 2003; Bartholomäus   
et al., 2008). The crystal structure of the Aquifex aeolicus 
leucine transporter LeuTAa (a bacterial orthologue of the 
mammalian SLC6 neurotransmitter transporters) reveals 
a dimer, with transmembrane domains (TMs) 9 and 12 
probably providing the dimer interface (Yamashita et al., 
2005). There may also be higher-order oligomers (Kilic 
and Rudnick, 2000; Hastrup et al., 2003; Just et al., 2004; 
Bartholomäus et al., 2008).
Sequence elements in the cytoplasmic N and C ter-
mini exert additional control over trafficking. They can 
serve as substrates for cytosolic regulators such as ki-
nases or as motifs for interactions with other proteins, 
including postsynaptic density 95/discs large/zona oc-
cludens 1 (PDZ) domain–containing and soluble N-eth-
ylmaleimide–sensitive fusion receptor proteins, which 
determine the insertion and withdrawal of transporter 
complexes from the cell surface (Loder and Melikian, 
2003; Torres et al., 2003; Farhan et al., 2004; McHugh   
et al., 2004; Miranda et al., 2004; Holton et al., 2005; 
Quick, 2006; Boudanova et al., 2008).
We wish to understand quantitative aspects of GAT1 
in synaptic transmission. To facilitate this goal, one must 
study  transporters  that  are  expressed  in  appropriate 
cells  at  normal  levels  and  at  normal  locations.  Most   
previous studies involve expression in heterologous ex-
pression systems in which the transporter is greatly over-
expressed  and/or  has  the  potential  to  associate  with 
incorrect partner proteins. Here, we describe the con-
struction of 19 new fluorescent mouse GAT1 (mGAT1) 
transporters tagged with either cyan or yellow fluores-
cent proteins (CFP and YFP, respectively; XFP collec-
tively). The majority of the designs are fusions of the 
XFP onto the mGAT1 C terminus with additional modi-
fications to preserve wild-type trafficking and assembly. 
We  report  functional  characterization  of  these  con-
structs with a quantitative [
3H]GABA uptake assay in 
which neither protein expression levels nor substrate 
transport has reached maximum when the transporter 
is expressed in mouse neuroblastoma 2a (N2a) cells (a 
neuron-like cell line); we present this expression system 
as an optimal one for the characterization of transiently 
expressed  neuronal  transporters.  The  assay  revealed 
that several of these fluorescent mGAT1 transporters 
were functionally identical to wild-type mGAT1.
We applied Förster resonance energy transfer (FRET) 
techniques  to  study  the  assembly  of  the  fluorescent 
mGAT1s. We especially evaluated, by pixel-by-pixel analy-
sis of sensitized emission FRET, the local oligomeriza-
tion of each fluorescent transporter construct in various 
subcellular compartments of a living cell. We conclude 
that pixel-by-pixel analysis of FRET has the ability to dis-
tinguish  between  subsurface  and  membrane-inserted   Moss et al. 491
We compared the function of the wild-type mGAT1 with our 
original  fluorescent  construct,  mGAT10GFP  (previously  called 
mGAT1-GFP) (Chiu et al., 2002), when expressed in the mouse 
N2a  or  human  HEK  293T  cell  lines.  Previous  data  show  that 
mGAT10GFP has a major trafficking deficit in vivo (Chiu et al., 
2002) because this construct design disrupts an endogenous PDZ-
interacting  epitope  (-AYI-CO2
)  at  the  mGAT1  C  terminus  of 
mGAT1 (Imoukhuede et al., 2009). The N2a cell line is both neu-
ronal and murine in origin and may possess much of the neces-
sary cellular machinery to process and traffic mGAT1 correctly; 
HEK 293T cells are a model human line frequently used to assess 
the function of plasma membrane proteins. 0, 50, 100, 250, or 
500 ng of wild-type mGAT1 plasmid or an equimolar amount of 
mGAT10GFP or pcDNA3.1(+) plasmid was transfected in 12-well 
plates. 20-min [
3H]GABA uptake experiments were performed in 
both low (2.5 µM) and high (80 µM) extracellular GABA concen-
trations ([GABA]O). Details of the [
3H]GABA uptake assay are in 
the supplemental material.
[
3H]GABA  uptake  in  N2a  cells  transfected  with  wild-type 
mGAT1 remained in the linear range, with respect to cDNA trans-
fected, at cDNA levels ≤100 ng cDNA/well in both 2.5 and 80 µM 
[GABA]O (Fig. 1, A and B). The measured [
3H]GABA uptake ap-
proached a limit for transfections ≥250 ng cDNA/well. Impor-
tantly, compared with the wild-type mGAT1 control, the [
3H]GABA 
uptake by N2a cells transfected with the mGAT10GFP construct 
A linear [
3H]GABA uptake assay in a neuronal cell line
To evaluate the function of fluorescently modified mGAT1 con-
structs relative to wild type, we sought to establish an uptake assay 
in an appropriate expression system that faithfully reports any 
functional  changes  caused  by  the  introduction  of  the  fluoro-
phore. In gene transfer experiments, quantitative analysis of pro-
tein function can be vitiated by several mechanisms that cause a 
“ceiling,” “maximum,” “limit,” “plateau,” “leveling off,” or “satura-
tion” of measured uptake. The nouns in quotes have recently con-
noted various phenomena, but we use the verb “to exceed” for 
each specific effect that we sought to avoid.
(A)  The  quantity  of  template  cDNA  transfected  into  the   
cell  may  exceed  the  capacity  of  the  cell’s  protein  synthetic 
machinery.
(B) The quantity of overexpressed protein may exceed the ca-
pability of the cell’s posttranslational processing, sorting, or traf-
ficking mechanisms.
(C) The substrate concentration may lie outside a linear region 
of the dose–response relation. For transporters, Michaelis-Men-
ten analyses describe a maximum transport velocity (Vmax) of the 
neurotransmitter  transporter  at  substrate  concentrations  that 
substantially exceed the Km.
(D) Net substrate flux may exceed the capacity of the cell’s ef-
flux  pumps,  organelle  pumps,  or  simple  diffusional  removal, 
leading to partial or complete equilibration.
Figure 1.  Establishing a lin-
early responding [
3H]GABA 
uptake assay in an appropri-
ate cell type. 50, 100, 250, or 
500  ng  of  wild-type  mGAT1   
plasmid  or  an  equimolar 
amount  of  mGAT10GFP  or 
pcDNA3.1(+)  plasmid  was 
transfected/well. 20-min up-
take  assays  were  performed 
on  transfected  N2a  cells  in   
2.5  µM  (A)  or  80  µM  (B) 
[GABA]O.  (C)  Identical   
transfections  were  per-
formed  in  HEK  293T  cells, 
and  20-min  uptake  assays 
were  performed  in  2.5  µM 
of  extracellular  [GABA]O. 
Each  point  represents  the   
mean of six transfections ± 
SEM. (D) Comparison of the   
fluorescence volume density 
of mGAT10GFP expressed in 
N2a and HEK 293T cells. **, 
significant  difference  as  de-
termined by Student’s t test; 
P  ≤  0.01.  Summed  Z-stack 
images of representative N2a   
(E) and HEK 293T cells (F)   
expressing  mGAT10GFP.  Bar,   
10  µm.  Time  course  experi-
ments  were  performed  in 
2.5  µM  (G)  or  80  µM  (H) 
[GABA]O on N2a cells trans-
fected  with  100  ng/well  of 
wild-type mGAT1 plasmid or 
an equimolar amount of the 
pcDNA3.1(+)  plasmid.  Each   
data point represents the mean 
of six transfections ± SEM.492 NFRET resolves GAT1 oligomerization state and anchoring
Turbo Cx Hotstart polymerase with 5 and 3 extensions corre-
sponding to the 20–22-nt regions that flanked the intended site of 
insertion, such that the PCR product integrated in-frame immedi-
ately after the fluorophore sequence when used as the primers in 
a subsequent QuikChange II XL mutagenesis PCR reaction. For 
mGAT1XFP*, we simply added a GTC codon for Val after the fluoro-
phore ORF.
Fig. 2 displays the protein sequences of the modified regions of 
mGAT1  for  each  fluorescent  construct.  mGAT10CFP  and 
mGAT10YFP repeated the fusion design of mGAT10GFP but with 
the fluorophore exchanged as annotated. The three C-terminal 
residues of the mGAT0XFP fusions are -YKI-CO2
, which com-
prises a broadly defined consensus PDZ class II–interacting motif 
(X--X-, where  designates a hydrophobic residue and X any 
residue) (Sheng and Sala, 2001; Hung and Sheng, 2002). We 
searched the Ensembl databases using Biomart (http://www.ebi 
.ac.uk/biomart) (Spudich et al., 2007) and applied the GO:0005886 
“plasma membrane” cellular component filter. The search identi-
fied  no  known  membrane  proteins  possessing  the  -YKI-CO2
  
C-terminal sequence. In the mGAT1XFP* constructs, we defined 
the terminal residue P(0) more narrowly, changing the terminal 
isoleucine  residue  present  in  mGAT10XFP  to  a  valine  in 
mGAT1XFP*  (Fig.  2).  The  resulting  C-terminal  sequence,   
-YKV-CO2
, reconstituted a functional PDZ class II–interacting motif 
present in Ephrin B receptors, a class that relies on interactions 
with the PDZ domain–containing proteins for clustering (Torres 
et al., 1998; Brückner et al., 1999; Lin et al., 1999; Madsen et al., 
2005).  Other  constructs  in  the  C-terminal  XFP  fusion  series, 
mGAT1XFP3, mGAT1XFP8, mGAT1XFP20, mGAT1XFP28, and 
mGAT1XFP45, had the most C-terminal 3, 8, 20, 28, or 45 residues 
of the hGAT1 appended after the mGAT1XFP fusion (Fig. 2). 
The differences in nucleotide sequence between the hGAT1 and 
mGAT1 C termini were a useful source of positive identification 
when we analyzed the clones during construction.
PCR  integration  was  applied  to  amplify  and  insert  EYFP  or 
ECFP directly between residues R565 and L566, I570 and Q571, 
or V577 and R578 of mGAT1 to generate the mGAT1
5xxXFP
5xxCT 
constructs (Fig. 2). The site of XFP insertion in GAT1 is high-
lighted in the nomenclatures for these constructs by superscript 
residue numbers flanking the fluorophore, and the “CT” denotes 
that the insertion occurs within the C terminus.
The EYFP or ECFP ORFs with 15 additional codons from the 
downstream MCS of pEYFP-C1 or pECFP-C1 vectors were ampli-
fied and fused via PCR integration directly onto the 5 end of the 
mGAT1 ORF in pcDNA3.1(+) to generate the XFP15mGAT1 
N-terminally tagged constructs.
Surface biotinylation
Surface biotinylation experiments were performed as described 
previously (Hu and Quick, 2008). The details are in the supple-
mental material.
Confocal Imaging
Transfections for confocal imaging were performed as described 
for uptake assays but scaled up appropriately according to Table S1 
for transfections in 35-mm culture dishes. Live cells grown on   
14-mm  glass-bottom  culture  dishes  (MatTek)  precoated  with 
0.05% PEI were washed once with room temperature Krebs-Ringer-
HEPES buffer and observed in the same solution (Ramamoorthy 
et al., 1998). Live cells were imaged at room temperature on an 
Eclipse C1si laser-scanning confocal microscope equipped with a 
63×, 1.4 numerical aperture VC Plan Apo oil objective and a 32-an-
ode photomultiplier tube (Nikon). Where required, images were 
linearly unmixed using the EZ-C1 software (Nikon) for the emis-
sion spectra of the fluorophores of interest using reference spectra 
individually compiled for each fluorophore expressed in the same 
cell  type  and  imaged  under  identical  experimental  conditions. 
was reduced (by 28–65%) for all cDNA transfection amounts in 
both 2.5 and 80 µM [GABA]O, reproducing the functional deficit 
reported for synaptosome preparations from mGAT10GFP knock-
in mice (Chiu et al., 2002). On the other hand, HEK 293T cells 
did not replicate this known functional deficit when expressing 
the mGAT10GFP construct; [
3H]GABA uptake reached a limit in 
2.5 µM [GABA]O in cells transfected with as little as 100 ng cDNA/
well of wild-type mGAT1 plasmid (V100 ng = 83.5 ± 1.9 fmol/µg/
min; calculated maximum = 86.9 ± 2.4 fmol/µg/min; Fig. 1 C). 
Furthermore, when the variable parameter was the mass of cDNA 
transfected in HEK 293T cells, the maximum calculated mGAT-
10GFP [
3H]GABA flux (93.5 ± 17.9 fmol/µg/min) was not signifi-
cantly different from wild-type mGAT1 (Fig. 1 C).
Why does the HEK 293T cell assay fail to replicate the func-
tional deficit linked to the PDZ interaction? We suspected that 
this failure occurs because the HEK 293T cell assay exceeds a limit 
associated with one of points A–D above. We tested the relative 
expression of total mGAT1 protein per cell in HEK 293T cells 
compared with N2a cells by measuring the absolute fluorescence 
intensity of mGAT10GFP when expressed in each cell type. 250 ng 
mGAT10GFP cDNA was transfected per 35-mm dish of 3.5 × 10
5 
cells (equivalent per cell to 100 ng cDNA per 12-well plate of   
1.4 × 10
5 cells; Table S1). Images of complete cells (0.5-µm step   
Z-stack) were acquired 48 h after transfection. Integrated fluores-
cence  measurements  determined  that  the  volume  density  of 
mGAT10GFP expressed in HEK 293T cells was 4.9-fold greater 
than when expressed in N2a cells (Fig. 1, D–F). We concluded 
(a) that N2a cells are the more suitable cell type for our experi-
ments and (b) that one should transfect 100 ng/well of wild-type 
mGAT1 plasmid or its equimolar amount per unit surface in other 
well  sizes.  In  addition,  under  these  transfection  conditions, 
[
3H]GABA uptake remained linear, with respect to the assay dura-
tion, for ≤60 min in both 2.5 or 80 µM [GABA]O: linear regression 
analysis of the 3-, 10-, 20-, and 60-min data points revealed r
2 = 
0.997 and 0.989, respectively (Fig. 1, G and H).
In summary, we believe that the assay conditions faithfully re-
ported changes caused by the mutations that we studied. We be-
lieve these conditions also rendered the optical measurements 
sensitive to such mutations.
Design and cloning of fluorescent mGAT1 constructs
We generated 19 new fluorescent mGAT1 constructs to study traf-
ficking and oligomerization of the GAT1 transporter. The goal 
was to generate fluorescent mGAT1 proteins that (a) assembled 
and trafficked as wild type and (b) gave robust FRET efficiencies 
when  the  transporter  oligomerized.  Wild-type  mGAT1  and 
mGAT10GFP constructs have been described previously (Chiu 
et al., 2002). The new fluorescent mGAT1 constructs described in 
this study were designed to rectify trafficking deficits of mGAT10GFP; 
in  addition,  we  exchanged  the  GFP  fluorophore  for  ECFP  or 
EYFP containing the “monomeric” A206K mutation to avoid dis-
tortions caused by dimerization motifs within the ECFP and EYFP 
proteins (Zacharias et al., 2002) and to facilitate the study of pro-
tein–protein interactions by FRET.
To  generate  the  fluorescent  mutants  mGAT10XFP  and 
mGAT1XFP* through mGAT1XFP45, the wild-type mGAT1 open 
reading frame (ORF) was subcloned without its original stop co-
don into the HindIII and EcoRI sites of the pcDNA3.1(+) expres-
sion vector multiple cloning site (MCS). XFP ORFs were then 
subcloned downstream from and in frame with the mGAT1 ORF 
at the NotI and XbaI sites of the pcDNA3.1(+) MCS. This resulted 
in a 12–amino acid spacer between the end of the mGAT1 se-
quence and the beginning of the fluorophore. We modified a 
method for the integration of PCR fragments without the use of 
restriction enzymes (Geiser et al., 2001) to add the final 3, 8, 20, 
28, or 45 codons of the human GAT1 (hGAT1) ORF. These were 
amplified from a source plasmid using the proof-reading Pfu-  Moss et al. 493
based  on  microscopic  images  (Wallrabe  and  Periasamy,  2005; 
Jares-Erijman and Jovin, 2006). First, in a specimen expressing 
both  donor-  and  acceptor-tagged  molecules,  the  existence  of 
FRET causes a decrease in the donor intensity, proportional to 
the number of donor-tagged molecules that interact with accep-
tor-tagged molecules. Thus, “acceptor photobleach” FRET directly 
measures E by quantifying the increase in the donor intensity after 
Quantification of images was performed using ImageJ software ver-
sion 1.41 (Abramoff et al., 2004). Colocalization calculations were 
performed using the Colocalization Finder plug-in for ImageJ.
FRET
FRET efficiency E is defined by the Förster equation (Lakowicz, 
2006a). Two classes of techniques provide approximate E values 
Figure 2.  Schematics of fluorescent mGAT1 construct designs and primary sequence alignments of the regions that are fused with XFP. 
In each schematic, the mGAT1 peptide is illustrated as a black bar, and TMs are marked as superimposed numbered boxes. TM12 is 
highlighted in magenta. Linkers deriving from cloning vector are shown in red, and the XFP moiety is shown as a cyan and yellow box. 
Additional hGAT1 sequence is shown as a dark blue box. #, a variable number of residues depending on the construct design. All sche-
matics and their internal features are scaled according to sequence length. The three classes of florescent mGAT1 fusions, C-terminal 
additions, C-terminal fusions, and N-terminal additions are displayed with their names to the left. For the fusions of XFP to the mGAT1 
C terminus, only the last 14 residues of the fluorophore and any appended hGAT1 or other sequence are displayed. For the mGAT1 
C-terminal XFP insertions, the regions immediately adjacent to the insertion site and the first four and last four residues of the XFP are 
displayed. Displayed GAT1 C-terminal sequences are numbered with the terminal residue being P(0); upstream sequence positions are 
negative. Other important highlighted regions include: fluorophore sequence (GFP in green; XFP in light blue), the terminal hydro-
phobic residues of mGAT10GFP and mGAT1XFP* (purple), the endogenous GAT1 class II PDZ–interacting motif -AYI (dark green), 
mouse or hGAT1 TM12 sequence (magenta), nonclassical endocytic motifs homologous to FREKLAYAIT in mDAT (conserved residues 
underlined) (Holton et al., 2005; Boudanova et al., 2008), RL or RI ER export motif (bold) (Farhan et al., 2007), and VMI or VMV 
(bold) ER–Golgi intermediate compartment export motif (Farhan et al., 2008). XFP sequence position in XFP15mGAT1 constructs is 
displayed below the sequence in blue, and mGAT1 numbering is in black. Linker sequence between XFP and mGAT1 is shown in red.494 NFRET resolves GAT1 oligomerization state and anchoring
each  region  of  interest  (ROI).  Extreme  outliers  (pixels  with 
NFRET  amplitudes  greater  than  three  times  the  interquartile 
range [IQR]) and pixels within an ROI with an NFRET amplitude 
of 0 were eliminated from the calculations. All-pixel NFRET amp-
litude distributions for a given collection of cells, or of subregions, 
were summarized as histograms with a bin size of 0.02 NFRET 
units. Distributions were best fit with two or three Gaussians. Fit-
ting concluded when R
2 ≥ 0.99.
To calculate FRET efficiency from sensitized emission experi-
ments, one needs to modify Eq. 1 because it is not possible to di-
rectly  measure  ID  from  such  samples.  Because  the  sensitized 
emission of the acceptor is due to the quenching of the donor in 
the presence of the acceptor, ID can be substituted in Eq. 1 by add-
ing the nF signal amplitude to the amplitude of the donor fluo-
rescence in the presence of acceptor IDA (Elangovan et al., 2003). 
Thus, we calculated FRET efficiency E as
  E
I
I nF
DA
DA
= −
+

 

  1 .    (4)
Radial analysis of NFRET amplitude distributions
The radial NFRET amplitude distributions describe the fractional 
distance of pixel p to the cell edge w from the cell center c (see 
Fig. 13 A). Full details of the method to calculate the mean frac-
tional displacement from c for the thousands of pixels in each 
NFRET amplitude percentile group are included in the supple-
mental material.
Data analyses
Data analyses were performed using Origin 7.0 (OriginLab) and 
MATLAB R2008a (The MathWorks) software.
Online supplemental material
The supplemental material includes descriptions of the methods 
for transfection, uptake, surface biotinylation, and radial analysis 
of NFRET amplitude distributions, a table of the cell densities 
and  transfection  parameters  required  to  achieve  nonsaturated 
transient mGAT1 expression in N2a cells (Table S1), and images 
of the subcellular localization of ER and trans-Golgi in N2a cells 
(Fig. S1). The online supplemental material is available at http://
www.jgp.org/cgi/content/full/jgp.200910314/DC1.
R E S U LT S
Several mGAT1 C-terminal fluorophore fusions display 
wild-type function and surface localization
We studied the subcellular localization of the mGAT1 
C-terminal  fluorophore  addition  constructs  by  laser-
scanning confocal fluorescence microscopy (Fig. 3) and 
compared  their  function  to  nonfluorescent  wild-type 
mGAT1 in [
3H]GABA uptake assays (Fig. 4 A). With the 
optimized [
3H]GABA uptake assays described in Mate-
rials and methods, the major source of variability was 
apparently unavoidable variations in cell growth. There-
fore, where appropriate, we used side-by-side assays (as 
in Figs. 4 A and 5 B); in such assays, we believe that dif-
ferences in substrate transport velocity of ≥25% reflect 
real differences in the membrane levels of functional 
transporters. The mGAT10XFP constructs display fluo-
rescence throughout the cytoplasm; at the periphery of 
the cells (that is, in the region near large amounts of 
photobleach of the acceptor (although artifacts including acceptor 
photoconversion and donor photobleach can distort this mea-
surement) (Rizzo et al., 2006). Second, the acceptor displays 
sensitized emission during excitation of the donor. Measurements 
of such “sensitized FRET” or “sensitized emission FRET” preserve 
the fluorophores in the sample and require only a single spec-
trally resolved image rather than a time series, but the acquired 
FRET index (an indirect measure of E) (Elangovan et al., 2003) 
responds nonlinearly to variations in the extent of interaction be-
tween fluorophore-tagged molecules (Gordon et al., 1998). This 
paper  distinguishes  between  acceptor  photobleach  FRET  and 
sensitized FRET measurements, as appropriate.
Acceptor photobleach FRET
Live  N2a  cells  were  visualized  at  room  temperature  in  Krebs-
Ringer-HEPES buffer 48 h after transfection using either an in-
verted  LSM  510  Meta  laser-scanning  confocal  microscope 
equipped with an Achroplan IR 63×, 1.4 numerical aperture oil-
immersion objective and the meta array of photomultiplier tubes 
(Carl Zeiss, Inc.) or the Eclipse C1si LSCM. Photobleaching was 
performed as described previously (Son et al., 2009). FRET effi-
ciency (E) was calculated:
  E
I
I
DA
D
= −

 

  1    (1)
IDA  represents  the  normalized  fluorescence  intensity  of  CFP 
(100%) in the presence of nonbleached acceptor. ID represents 
the normalized fluorescence intensity of CFP after 100% photo-
bleach of the acceptor, YFP. The ID value was extrapolated from a 
scatter plot of the percentage increase of CFP versus the percent-
age decrease of YFP for each cell (Nashmi et al., 2003).
Quantification of pixel-by-pixel FRET from sensitized  
acceptor emission
Live cells were imaged using the Eclipse C1si LSCM. Full emission 
spectra images were acquired in 5-nm bins between 452 and 612 nm, 
linearly  unmixed,  and  complied  into  donor  spectral  bleed-
through stacks, acceptor spectral bleed-through stacks, and sam-
ple image stacks as described previously (Son et al., 2009). The 
Pix-FRET ImageJ plug-in was used to determine the CFP and YFP 
bleed-through values and to calculate the net FRET (nF) and nor-
malized FRET (NFRET) in each pixel (Feige et al., 2005). With 
the background and bleed-through corrections set, the nF for 
each pixel as described by Eq. 2 was calculated and the data out-
put as 32-bit images.
  nF I I BT I BT FRET CFP CFP YFP YFP = − × − ×    (2)
nF was normalized for donor and acceptor expression levels ac-
cording to Eq. 3 to calculate NFRET and to generate a 32-bit 
NFRET image (Xia and Liu, 2001).
  NFRET
I I BT I BT
I I
FRET CFP CFP YFP YFP
CFP YFP
=
− × − ×
×
   (3)
Normalizing nF to the square root of the product of the donor 
and acceptor fluorescence intensities controlled for large varia-
tions in the expression levels of each fluorophore between differ-
ent  cells  and  provided  a  measure  of  FRET  that  is  readily 
comparable  between  different  samples  (Xia  and  Liu,  2001).   
Gordon et al. (1998) explained that NFRET is a relative measure 
of the dissociation constant (Kd) for the binding interaction be-
tween proteins that increases monotonically (but not linearly) at 
smaller  values  of  Kd.  Box  plots  were  constructed  showing  the 
mean NFRET, the median NFRET, and the spread of the data for   Moss et al. 495
poor function of these mGAT10XFP constructs was ex-
pected  from  the  functional  deficits  of  the  knock-in 
mouse strain. Because the YFP-CFP FRET pair forms 
the  basis  of  most  measurements,  we  have  not  con-
structed additional GFP-containing mGAT1 mutants.
The  constructs  mGAT1XFP*,  mGAT1XFP3, 
mGAT1XFP8,  mGAT1XFP20,  and  mGAT1XFP28  ex-
hibited strong localization in the cell periphery (Fig. 3). 
We determined that a large part of this fluorescence dis-
tribution arose from surface membrane expression. 
Three complementary assay types provide evidence of 
this point. (1) For each of these five constructs, [
3H]GABA 
uptake from transfected N2a cells did not differ signifi-
cantly from wild-type mGAT1 (Fig. 4 A). (2) Surface 
biotinylation  experiments  determined  that  38–44% 
of  the  total  expressed  mGAT1XFP*,  mGAT1XFP3, 
mGAT1XFP8, mGAT1XFP20, or mGAT1XFP28 protein 
inserted into the plasma membrane, which again did 
not differ significantly from wild-type mGAT1 (43%; 
Fig. 4 B). (3) Concentration dependence of [
3H]GABA 
uptake for mGAT1XFP*, mGAT1XFP8, mGAT1YFP3, and 
mGAT1YFP20 was, again, identical to wild-type mGAT1 
(Fig. 4, C–E). Each panel of Fig. 4 (C–E) presents the 
plasma membrane), the fluorescence is brighter (Fig. 3). 
Fig. 4 A shows that this peripherally enhanced fluores-
cence does not represent complete plasma membrane 
insertion of mGAT10XFP constructs: [
3H]GABA uptake 
of both mGAT10YFP and mGAT10CFP functioned less 
well (41 ± 1 and 60 ± 8%, respectively) compared with 
wild-type mGAT1. This poor function was not revealed by 
our previous expression system in HEK 293T cells (Chiu 
et al., 2002), but a functional deficiency was observed 
when neurons of mGAT10GFP knock-in mice exhibited 
reduced  [
3H]GABA  uptake  compared  with  wild-type 
mice. We therefore believe that the present assay system 
has good relevance to several processes that control func-
tional levels of mGAT1 expression in neurons.
We include data for mGAT10GFP for primarily histor-
ical  reasons.  Its  poor  function  in  a  knock-in  mouse 
strain (Chiu et al., 2002) provided a major motivation 
for  the  present  study.  Surprisingly,  the  mGAT10GFP 
functioned even less well (22 ± 2% of wild type) than 
the corresponding YFP and CFP constructs. We have 
not systematically explored the source of the differences 
among the functional data for the three fluorophore 
fusions (YFP, CFP, and GFP), but as noted, the generally 
Figure 3.  Expression and subcellular localization of 
C-terminal XFP addition mGAT1 constructs in N2a cells. 
Each panel displays representative fluorescence micros-
copy images of live N2a cells expressing each C-terminal 
addition construct 48 h after transfection using the linear 
range parameters described in Materials and methods. The 
nomenclature for each construct has been abbreviated 
to remove the “mGAT1” because this element is common 
to all the constructs displayed (i.e., mGAT10GFP = 0GFP 
and mGAT1YFP8 = YFP8). Bars, 10 µm.496 NFRET resolves GAT1 oligomerization state and anchoring
tein sample aggregated in the well of the acrylamide 
gels and did not separate under electrophoresis. Appar-
ently, the mGAT1XFP45 constructs suffer from one or 
more major deficits.
Diminished mGAT1 function results if XFP is incorporated 
close to TM12
In  the  mGAT1
565XFP
566CT  and  mGAT1
570XFP
571CT 
constructs, the XFP insertion sites interrupted motifs 
that are important in the regulation of mGAT1 trafficking 
(Holton et al., 2005; Farhan et al., 2007, 2008; Boudanova 
et al., 2008). However, the C terminus region interrupted 
by our mGAT1
577XFP
578CT construct has little influence 
on mGAT1 oligomerization and trafficking, according to 
a previous report (Farhan et al., 2004). Fig. 5 A displays 
the subcellular localization of the mGAT1
565XFP
566CT, 
mGAT1
570XFP
571CT, and mGAT1
577XFP
578CT constructs. 
concentration  dependence  data  for  two  fluorescent 
constructs  versus  wild-type  mGAT1  transfections  per-
formed in side-by-side assays. Within each set of experi-
ments,  the  Km  and  Vmax  for  the  fluorescently  tagged 
transporters did not differ significantly from those of 
wild-type mGAT1.
On the other hand, mGAT1XFP45 constructs were 
expressed primarily inside the cell (Fig. 3). This point is 
reported by markedly impaired [
3H]GABA uptake com-
pared with wild-type mGAT1 (mGAT1CFP45, 21 ± 2%; 
mGAT1YFP45, 22 ± 2%; Fig. 4 A) and by the very small 
fraction of the total mGAT1XFP45 protein that parti-
tioned into the plasma membrane in biotinylation as-
says (2.8 ± 0.6% compared with 44 ± 5% for wild type; 
Fig. 4 B). It should be noted that mGAT1XFP45 was 
particularly challenging to process during surface bio-
tinylation experiments because the majority of the pro-
Figure  4.  Functional characterization of C-ter-
minal fusion mGAT1XFP constructs. (A) 20-min 
[
3H]GABA  uptake  from  N2a  cells  transfected 
with 100 ng/well of mGAT1 wild-type plasmid, 
an equimolar amount of the fluorescently tagged 
mGAT1 plasmids, or blank pcDNA3.1(+) vector. 
100% wild-type [
3H]GABA uptake is 21.4 ± 1.8 
fmol/µg/min. Results represent the mean ± SEM 
of 6–18 transfections for each construct. *, signifi-
cant difference compared with wild-type; P ≤ 0.05 
(ANOVA with Tukey’s post-hoc test). (B) Surface 
biotinylation experiments comparing the plasma 
membrane partitioning of mGAT1XFP constructs 
that had displayed wild-type–like [
3H]GABA up-
take  and  one  that  presents  an  uptake  deficit. 
Representative bands of the biotinylated mGAT1 
surface fractions are displayed above the graph. 
Bands are arranged in the image to correspond 
to the appropriate column in the graph. Results 
represent the mean ± SEM of five to eight trans-
fections for each construct. *, significant differ-
ence compared with wild-type; P ≤ 0.05 (one-way 
ANOVA with Tukey’s post-hoc test). (C–E) GABA 
concentration dependence of six selected con-
structs whose uptake was closest to wild type in A. 
Each panel presents three groups of experiments 
in which the constructs were tested in pairs ver-
sus wild-type mGAT1 (100 ng cDNA transfected 
per 12-well plate well). The nonspecific uptake 
was  determined  from  wells  transfected  with 
empty pcDNA3.1(+) vector and subtracted from 
the test samples, but is displayed for reference in 
each plot. No significant difference was found 
between any of these fluorescent mGAT1 con-
structs and wild-type mGAT1 for all concentra-
tions,  as  determined  by  one-way  ANOVA  with 
Tukey’s post hoc test (P ≤ 0.05). Data represent 
the mean uptake for each concentration ± SEM 
for six to nine transfections.  Moss et al. 497
C-terminal YFP insertions (Fig. 5 B). mGAT1
565YFP
566CT 
exhibited a marked deficit in uptake compared with wild-
type mGAT1. Uptake from N2a cells expressing mGAT1
570 
YFP
571CT was intermediate between mGAT1
565YFP
566CT 
and wild-type mGAT1. Uptake from mGAT1
577YFP
578CT-
expressing cells did not differ significantly from wild-
type mGAT1. In concentration–response experiments, 
the Km for mGAT1
577YFP
578CT also did not differ sig-
nificantly from wild-type mGAT1, and its Vmax was 78% 
that of wild type (Fig. 5 C). Thus, the presence of the 
XFP  fluorophores  between  the  C-terminal R565 and 
Q571 residues inhibited interactions required for nor-
mal trafficking of mGAT1 to the plasma membrane. 
Locating the XFP six residues more distally in the   
C terminus avoided such inhibitions and maintained 
These three construct designs expressed varying degrees 
of concentrated fluorescence at the periphery of the 
cells close to the plasma membrane as well as in intracel-
lular compartments. The intracellular localization was 
greatest in the mGAT1
565XFP
566CT constructs, and in 
many instances, expression was confined entirely to in-
tracellular compartments. This observation is exempli-
fied  by  the  mGAT1
565YFP
566CT  image  presented  in   
Fig. 5 A (21 of out of 79 cells imaged). Notably, all cells 
expressing mGAT1
570XFP
571CT or mGAT1
577XFP
578CT 
constructs exhibited some apparent plasma membrane 
localization,  with  mGAT1
577XFP
578CT  showing  strong 
fluorescence concentrated in the cell periphery (Fig. 5 A), 
similar to that observed for mGAT1XFP3-mGAT1XFP28. 
We studied the [
3H]GABA uptake properties of the 
Figure  5.  Expression  and  functional 
characterization  of  C-terminal  insertion 
mGAT1XFPCT constructs. (A) Each panel 
displays exemplar fluorescence microscopy 
images of live N2a cells expressing each of 
the  C-terminal  insertion  constructs  48  h 
after  transfection.  Note  that  the  subcel-
lular  distributions  of  mGAT1
565CFP
566CT 
and mGAT1
565YFP
566CT differ in the dis-
played  panels.  These  variations  are  not 
caused by the different fluorophores but 
are displayed to exemplify each of the two 
types of subcellular distributions observed 
for  this  construct  design.  Bars,  10  µm.   
(B) 20-min uptake of 2.5 µM GABA/25 nM 
[
3H]GABA  from  N2a  cells  transfected 
with  100  ng/well  of  mGAT1  wild-type 
plasmid,  an  equimolar  amount  of  the 
fluorescently  tagged  mGAT1  plasmids, 
or  blank  pcDNA3.1(+)  vector.  For  these 
experiments,  100%  wild-type  [
3H]GABA 
uptake is 5.3 ± 0.6 fmol/µg/min. Results 
represent the mean ± SEM of 6–12 trans-
fections for each construct. *, significant 
difference  compared  with  wild-type;  P  ≤ 
0.05 (ANOVA with Tukey’s post-hoc test). 
(C) GABA concentration dependence of 
mGAT1
577YFP
578CT  compared  with  wild-
type mGAT1. Each data point represents 
the  mean  ±  SEM  of  six  transfections  of 
each construct at each [GABA]O. (D) Left-
hand panels display representative expres-
sion pattern of XFP15mGAT1 constructs 
in N2a cells (bar, 10 µm) 48 h after trans-
fection.  Right-hand  graph  displays  the 
results of 20-min [
3H]GABA uptake from 
N2a cells transfected with 100 ng/well of 
mGAT1  wild-type  plasmid,  an  equimolar 
amount of the XFP15mGAT1 plasmids, or 
blank pcDNA3.1(+) vector. 100% wild-type 
[
3H]GABA uptake is 21.4 ± 1.8 fmol/µg/
min. Results represent the mean ± SEM 
of  18  wild-type  mGAT  transfections  and   
6  transfections  of  CFP15mGAT1  and   
YFP15mGAT1.  *,  significant  difference 
compared with wild-type; P ≤ 0.05 (ANOVA 
with Tukey’s post-hoc test).498 NFRET resolves GAT1 oligomerization state and anchoring
pairs and between mGAT1XFP8 pairs, which are C-ter-
minal GAT1–XFP fusion constructs that functioned like 
wild-type mGAT1 in both uptake and surface biotinyla-
tion experiments (Fig. 6). To quantify acceptor photo-
bleach  FRET  between  the  mGAT1  oligomers,  we 
constructed a scatter plot of the photobleach-induced 
changes in CFP and YFP fluorescence of each cell dur-
ing the entire bleaching time, fitted a regression line to 
the  data,  and  extrapolated  to  complete  YFP  photo-
bleach (Fig. 6 C). The extrapolated values of CFP pho-
torecovery for the mGAT1CFP*-mGAT1YFP* and the 
mGAT1CFP8-mGAT1YFP8 transfection pairs were 1.10 ± 
0.01 and 1.26 ± 0.01, respectively (Fig. 6 C). Eq. 1 yields 
calculated FRET efficiencies of 9% for mGAT1CFP8/
mGAT1YFP8 and 21% for mGAT1CFP*/mGAT1YFP*. 
For the C-terminal mGAT1XFP45 fusions, which have 
poor function, we detected no measurable FRET be-
tween mGAT1CFP45-mGAT1YFP45 coexpressed in N2a 
cells (Fig. 6 D). Likewise, no detectable acceptor photo-
bleach FRET signal was recorded from cells coexpressing 
the CFP15mGAT1-YFP15mGAT1 constructs (Fig. 6 E).
Pixel-based FRET reveals several components to the total 
FRET signal amplitude distribution
The acceptor photobleach FRET data gave a reasonable 
report of the average FRET signal from confocal images 
of whole N2a cells expressing fluorescent GAT1 pro-
tomers. However, acceptor photobleaching is not opti-
mal for measurement of FRET at subcellular resolution 
in live cells. Attempting acceptor photobleach FRET in 
mGAT1
577XFP
578CT transporters at the plasma mem-
brane  in numbers almost equivalent to the wild-type 
nonfluorescent mGAT1.
N-terminal fluorophore additions impair mGAT1 function 
and trafficking
The N-terminally labeled XFP15mGAT1 fusions were 
primarily retained within intracellular regions (Fig. 5 D) 
and displayed significantly reduced [
3H]GABA uptake 
compared with wild-type mGAT1 (CFP15mGAT1 35 ± 
2% and YFP15mGAT1 28 ± 6%; Fig. 5 E). This extended 
our previous experience with an N-terminally labeled 
GFPmGAT1 fusion that had only eight amino acids in 
its linker between the fluorophore and the mGAT1; the 
previous construct also failed to localize appropriately 
to the plasma membrane (Chiu et al., 2002).
Acceptor photobleach FRET with fluorescent mGAT1 
constructs shows that oligomerization is required  
for wild-type function
Dimerization/oligomerization of SLC6 transporter pro-
tomers is required for export of functional transporter 
from the ER to the plasma membrane (Farhan et al., 
2006; Bartholomäus et al., 2008). Therefore, fluores-
cent mGAT1 constructs that behaved functionally like 
wild-type mGAT1 were expected to form oligomers of 
mGAT1 protomers. We studied the assembly of our fluo-
rescent GAT1 constructs using the acceptor photobleach 
FRET technique (Nashmi et al., 2003). We first investi-
gated acceptor photobleach FRET between mGAT1XFP* 
Figure 6.  FRET assessed by acceptor photobleach. (A) Plots of acceptor photobleach and donor photorecovery for mGAT1CFP*/
mGAT1YFP* (n = 10) or (B) mGAT1CFP8/mGAT1YFP8 (n = 7) coexpressed in N2a cells. Data for each fluorophore were normalized to 
absolute fluorescence at time zero and fitted to a single exponential plus finite baseline:  y y A e
x x = +
− −
0 1
0 1 ( ( / )) τ . (C) A scatter plot of CFP 
photorecovery versus YFP photobleach for the FRET pairs in A and B. FRET efficiency for each transfection was calculated by extrapolat-
ing to the linear regression fits to YFP photobleach = 1.0. The Y-intersect (ID) was then entered into Eq. 1. (D) Plot of acceptor photo-
bleach and donor photorecovery for mGAT1CFP45/mGAT1YFP45 (n = 12). (E) Mean acceptor photobleach and donor photorecovery 
for the CFP15mGAT1/YFP15mGAT1 cotransfection in N2a cells (n = 5).  Moss et al. 499
lyzed the number of NFRET components, their am-
plitudes,  and  the  proportion  of  the  total  NFRET 
distribution represented by each component. Compar-
ing these data with the measured functional properties 
of each construct suggested that the subcomponents of 
NFRET  distributions  may  represent  mGAT1  dimers, 
higher-order mGAT1 oligomers, and mGAT1 oligomers 
interacting with PDZ domain–containing complexes, as 
explained in the Discussion and Appendix.
Negative controls with noninteracting membrane proteins
For the negative control, we expressed two fluorescently 
tagged  plasma  membrane  proteins,  mGAT1  and  the 
42 nAChR, which do not interact in N2a cells (Drenan 
et al., 2008). The mGAT1CFP8 construct was cotrans-
fected with plasmids that assemble 4YFP/2 nAChRs 
(Nashmi et al., 2003; Khakh et al., 2005; Drenan et al., 
2008;  Son  et  al.,  2009).  Control  transfections  of 
mGAT1CFP8/4/2 and mGAT1/4YFP/2 plasmids 
(250 ng of each plasmid) were also performed (a) to 
subcellularly differentiated ROIs would introduce error 
in the temporal resolution because imaging would be 
far slower than the dynamics of transporter trafficking. 
To determine FRET in specific ROIs, we used a spec-
trally resolved, sensitized emission FRET approach that 
determines FRET in a sample on a pixel-by-pixel basis 
and during the few microseconds required to measure 
each pixel (pixels are 69-nm squares). The spectrally 
unmixed images provide data similar to the three-filter 
method reported by Xia and Liu (2001), but using an 
optically more efficient, simultaneous detection of pho-
tons. Furthermore, we included the NFRET amplitude 
of each pixel as a datum in the analysis rather than aver-
aging the signal amplitudes of all the pixels in an ROI. 
As shown below, this technique revealed that (a) FRET 
varies among subcellular compartments as defined by 
each ROI, and (b) within every ROI, the total NFRET 
distribution consists of two or three subcomponents, 
each with a distinct mean NFRET amplitude. For each 
fluorescent mGAT1 construct design studied, we ana-
Figure 7.  Pixel-by-pixel quantification of sensitized emission FRET between mGAT1CFP8 and 4YFP2 nAChRs. A negative control 
experiment. (A; from left to right) mGAT1CFP8 fluorescence and 4YFP nAChR subunit fluorescence unmixed from an N2a cell coex-
pressing mGAT1CFP8, 4YFP nAChR subunit, and wild-type nonfluorescent 2 nAChR subunit (calibration bars in arbitrary calibration 
units [ACUs]). ROIs were used to determine FRET. The red-shaded area described the “peripheral” ROI, and the combined red and 
black areas correspond to the whole cell ROI. The fourth panel displays the NFRET image (calibration bar, NFRET × 100). Pixels with 
signal amplitude below threshold are shaded gray. Bars, 10 µm. (B) Box plots displaying the range of NFRET detected from these neg-
ative control data. The box highlights the IQR (Q1–Q3), the center line in the box indicates the median, and the closed square symbol 
represents the mean. The whiskers’ ends represent the boundaries of the lower and upper inner fences (1.5 × IQR). The × marks the first 
and 99th percentiles. The half-shaded diamond symbols indicate the absolute maximum and minimum data point in each set. The plots 
from the whole cell and peripheral ROIs are colored black and red, respectively, corresponding to the ROI color codes in A. The mean 
and median NFRET amplitudes for all pixels in each ROI are displayed in Table I. (C) Histograms displaying the distribution of pixel 
NFRET amplitudes for each condition (bin width, 0.02). Distributions for each ROI were fit to two Gaussian components. The individual 
components are shown as dashed lines, and the sum of the fit is shown as a solid line. The tables in each panel report the means of each 
component and the percentage of the pixels comprising each component.500 NFRET resolves GAT1 oligomerization state and anchoring
Figure  8.  Pixel-by-pixel quantification of sensitized emission FRET between mGAT1XFP* and mGAT1XFP8. (A; left two panels) 
mGAT1CFP* fluorescence and mGAT1YFP* fluorescence (calibration bars, ACUs). In the third panel, ROIs were used to determine 
NFRET. The red-shaded area described the “peripheral” ROI, the green-shaded area corresponds to the “perinuclear” ROI, the black 
and green region with the red area describes the “intracellular ROI,” and the combined red, green, and black areas correspond to the 
whole cell ROI. The fourth panel displays the NFRET image of the same cell (color calibration bar, NFRET × 100). The color code in 
the NFRET image includes negative and positive signal amplitudes. Pixels with signal amplitude below threshold are shaded gray. Bars,   
10 µm. (B) Box plots displaying NFRET for all pixels in each ROI of cells expressing mGAT1XFP*. The box, whiskers, and other data points 
are represented as in Fig. 7 B. Box plots for each ROI are colored according to the code described for A (ROI), and the intracellular data 
are colored blue. (C) Table of results for mGAT1XFP* transfections displaying the mean of each Gaussian component of the summed 
fit of the distributions in D and the percentage of the pixels comprising each component. (D) Distributions of NFRET signal amplitude 
per pixel for each ROI (bin width, 0.02) from mGAT1XFP*-expressing cells. The individual components are shown as dashed lines, and   Moss et al. 501
of efficient insertion into the plasma membrane (Chiu 
et al., 2002). The calculated peripheral NFRET for co-
expressed mGAT1CFP8 and 4YFP/2 nAChR was also 
negative (Fig. 7 B and Table I).
Fig. 7 C introduces frequency distributions of NFRET 
amplitudes from each pixel of several dozen cells. These 
data are binned to form all-pixel NFRET amplitude dis-
tributions: NFRET amplitude on the x axis and number 
of pixels on the y axis. Although the NFRET distribu-
tions for both ROIs for these negative control transfec-
tions were best fit with two Gaussians, both components 
had negative mean NFRET amplitudes (Fig. 7 C). These 
data confirm that the method detects no interaction be-
tween the 42 nAChR and GAT1 in intracellular re-
gions or in the cell periphery.
Region-specific FRET quantification reveals high FRET 
efficiency in the periphery of cells expressing fluorescent 
GAT1 constructs that exhibit wild-type function
To investigate FRET between fluorescent GAT1 fusions, 
we defined four ROIs for each cell imaged. These were 
named the “whole cell ROI,” the “intracellular ROI,” 
the “perinuclear ROI,” and the “peripheral ROI.” The 
whole cell and peripheral ROIs were defined in the con-
trol experiments. Intracellular ROI is the space within 
the concentrated fluorescence at the cell periphery, but 
subtracting the dark space occupied by the cell nucleus, 
and is densely filled by ER (Fig. S1 A). The perinuclear 
generate reference spectra and (b) to determine spec-
tral  bleedthrough  as  described  previously.  Both  fluo-
rescently  tagged  proteins  maintained  their  normal 
expression  pattern  when  coexpressed  in  N2a  cells 
(Fig.  7  A):  the  fluorescence  pattern  for  fluorescent 
4YFP2 nAChRs was uniform with little enhancement 
at the plasma membrane (Fig. 7 A), as described previ-
ously in N2a cells (Drenan et al., 2008; Son et al., 2009), 
and the fluorescence pattern for mGAT1CFP8 resem-
bled that of Fig. 3.
We defined a whole cell ROI that encompassed all the 
fluorescent pixels in the cell minus the nonfluorescent 
cell nucleus. The mean NFRET for all pixels within this 
ROI for cells coexpressing mGAT1CFP8 and 4YFP/2 
nAChR was negative, indicating that no FRET occurred 
and that there was some overcorrection for donor and 
acceptor bleedthrough when there was no FRET (Fig. 7 B 
and Table I).
Because the mGAT1CFP8 construct localized strongly 
in the cell periphery, we used this fluorescence to de-
fine a second ROI that contributed “peripheral NFRET.” 
The  peripheral  ROI  encompassed  both  the  plasma 
membrane and a narrow annulus (700 nm) of imme-
diately adjacent cytoplasm. We use this description 
because  constructs  such  as  mGAT10XFP  exhibit  con-
centrated  fluorescence  in  the  cell  periphery  due  to 
pooling of transporter-containing vesicles within 500 nm 
of the outer lipid bilayer of the cell, rather than because 
TA B L E   I
Average NFRET for all pixels measured in each ROI
Transfection
ROI NFRET
Whole Cell Intracellular Perinuclear Periphery
Mean
a Median IQR Pixels 
(×10
5)
Mean
a Median IQR Pixels 
(×10
5)
Mean
a Median IQR Pixels 
(×10
5)
Mean
a Median IQR Pixels 
(×10
5)
4YFP/2CFP/
mGAT1
0.20 0.20 0.09 3.9
4YFP/2/
mGAT1CFP8
0.08 0.08 0.31 4.3 0.14 0.13 0.12 0.7
mGAT1XFP* 0.10 0.10 0.09 7.3 0.10 0.09 0.09 4.7 0. 07 0.07 0.10 1.8 0. 11 0.11 0.11 2.2
mGAT1XFP8 0.10 0.09 0.10 7.7 0.09 0.07 0.07 4.0 0.08 0.07 0.06 1.2 0.13 0.11 0.14 3.3
mGAT1XFP45 0.04 0.02 0.14 3.1 0.03 0.01 0.13 2.5 0.08 0.05 0.18 0.9 0.01 0.004 0.12 0.2
mGAT1
565XFP
566CT 0.18 0.17 0.11 4.3 0.17 0.16 0.11 3.1 0.17 0.16 0.11 1.7 0.18 0.17 0.11 0.7
mGAT1
570XFP
571CT 0.12 0.11 0.09 4.5 0.11 0.10 0.09 3.0 0.11 0.11 0.07 1.5 0.12 0.11 0.09 0.9
mGAT1
577XFP
578CT 0.16 0.14 0.16 2.6 0.12 0.10 0.13 1.3 0.12 0.10 0.12 0.7 0.20 0.18 0.17 1.2
mGAT10XFP 0.13 0.11 0.11 23 0.13 0.12 0.11 15 0.12 0.11 0.10 3.9 0.11 0.09 0.10 7.6
aStandard error of the mean NFRET values range from 6 × 10
5 to 7 × 10
4.
the sum of the fit is shown as a solid line. (E) Representative fluorescence images of mGAT1XFP8-expressing N2a cells, the ROIs, and 
corresponding NFRET image. Calibration and color coding are as for A. (F) Box plots displaying NFRET for all pixels in each ROI of 
cells expressing mGAT1XFP8. Color coding and data are represented as in B. (G) Table of results for mGAT1XFP8 transfections display-
ing the mean of each Gaussian component of the summed fit of the distributions in H and the percentage of the pixels comprising each 
component. (H) Distributions of NFRET signal amplitude per pixel for each ROI (bin width, 0.02) from mGAT1XFP8-expressing cells. 
The individual components are shown as dashed lines, and their sum is shown as a solid line.
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ROI describes a concentrated region of fluorescence in 
cells expressing the fluorescent mGAT1 constructs adja-
cent to the cell nucleus; according to organelle mark-
ers, this ROI comprises mainly ER and Golgi (Fig. S1 B). 
Fluorescence images of cells coexpressing the CFP and 
YFP variants of fluorescent GAT1 fusions were acquired 
and processed as described above.
Sensitized FRET from cells expressing the wild-type–
like  C-terminal  fusion  constructs  mGAT1XFP*  and 
mGAT1XFP8 confirmed earlier acceptor photobleach 
FRET findings that oligomerization was required to ob-
serve  wild-type–like  function  from  our  fluorescent 
constructs (Fig. 8). In addition, for mGAT1XFP* and 
mGAT1XFP8, respectively, NFRET images showed that 
30.1 and 43.3% of the whole cell ROI NFRET signal 
came from the peripheral ROI (Fig. 8, A and E, and   
Table I). The mean NFRET amplitudes for all pixels   
in  an  ROI  for  N2a  cells  expressing  mGAT1XFP*  or 
mGAT1XFP8 constructs were greatest in the peripheral 
ROI compared with the intracellular or the perinuclear 
ROIs (Fig. 8, B and F, and Table I). Specifically, the 
ratios of NFRET in the peripheral ROI were 1.6- and 
1.7-fold  greater  than  in  the  perinuclear  ROIs  for 
mGAT1XFP* and mGAT1XFP8, respectively. Also, the 
reported NFRET from pixels in the peripheral ROI of 
mGATXFP8-expressing cells had a much broader IQR 
than  those  from  the  perinuclear  ROI  (Fig.  8  F  and   
Table I). mGAT1 oligomerization was therefore detected 
in all ROIs, but an additional molecular event, specifi-
cally  localized  to  the  periphery  of  cells  expressing 
mGAT1XFP*  and  mGAT1XFP8,  resulted  in  elevated 
FRET in this region. Analysis of the NFRET distribu-
tions from each ROI determined that the NFRET from 
the intracellular and perinuclear ROIs of mGAT1XFP*- 
or mGAT1XFP8-expressing cells were best fit with two 
Gaussians, both reporting positive mean NFRET. How-
ever, the whole cell ROIs and the peripheral ROIs were 
best fit with three Gaussians (Fig. 8, D and H). The 
highest-amplitude NFRET component (1.2- to 1.8-fold 
greater mean NFRET than from the intermediate-am-
plitude component) represented 27–30% of the pixels 
in the peripheral ROIs (Fig. 8, C, D, G, and H). Among 
the three subcellular ROIs, this highest-amplitude com-
ponent appeared only in the peripheral ROI and was 
accompanied by an 30% reduction in the peripheral 
ROI NFRET signal contributed by the lowest-amplitude 
component  when  compared  with  the  intracellular   
or perinuclear ROIs (Fig. 8, C, D, G, and H). Thus, 
for the wild-type–like functioning mGAT1XFP* and 
mGAT1XFP8, we infer that two different oligomeriza-
tion events were described by the low- and intermedi-
ate-amplitude components that were common to the 
NFRET distributions of all examined ROIs (see Discus-
sion and Appendix). In addition, elevated mean NFRET 
in the peripheral ROI versus intracellular regions cor-
responded to the third high-amplitude component 
in  the  peripheral ROI  NFRET  distribution. We  infer 
that a specific mGAT1 oligomerization or interaction 
event—the molecular correlate for the third high-amp-
litude NFRET component—is highly localized to the 
cell periphery.
Sensitized  NFRET  from  mGAT1XFP45,  which  re-
ported little function and no FRET by acceptor photo-
bleach analysis, was studied pixel by pixel (Fig. 9). This 
method  did  detect  some  mGAT1XFP45  oligomeriza-
tion in small regions. These pixels were too few to influ-
ence the whole cell averaging algorithms that calculated 
FRET  by  acceptor  photobleaching.  The  perinuclear 
ROI contained most of these small regions highlighted 
by the sensitized NFRET approach in mGAT1XFP45-
expressing specimens. The mean NFRET amplitude for 
all  pixels  in  the  perinuclear  ROI  resembled  that  re-
corded for mGAT1XFP* or mGAT1XFP8 (Fig. 9 B and 
Table I). For mGAT1XFP45, the FRETing pixels in the 
peripheral ROI contributed only 6.4% of the whole cell 
ROI NFRET signal, nonetheless indicating that some 
oligomerized mGAT1XFP45’s were exported from the 
perinuclear region and could eventually contribute to 
the small but significant [
3H]GABA uptake for this con-
struct in the functional assays. The NFRET distributions 
for all ROIs of mGATXFP45-expressing cells were best 
fit with two Gaussians, the first of which reported a neg-
ative mean NFRET (Fig. 9, C and D). The positive popu-
lation  made  up  >75%  of  the  NFRET  signal  in  the 
peripheral and perinuclear ROIs. We observed that the 
mean NFRET of the positive Gaussian component was 
1.4-fold larger in the peripheral ROI compared with the 
same component of the mGAT1XFP45 perinuclear ROI 
NFRET. Even though very few mGAT1XFP45 oligomers 
inserted into the plasma membrane, it appeared that 
those that did insert were subject to the same molecular 
event that caused increased FRET in the periphery of 
cells  expressing  wild-type  functioning  fluorescent 
mGAT1 constructs.
Next, we examined the FRET of the mGAT1
5xxXFP
5xxCT 
constructs, which show a graded improvement in func-
tion as the XFP moiety is moved downstream within the 
C terminus away from TM12 (Fig. 5). mGAT1
565XFP
566CT 
reported a robust mean NFRET amplitude for all pixels 
(≥0.17) in all ROIs examined (Fig. 10, A and B, and   
Table I), indicating that significant transporter oligo-
merization was occurring. However, the poor function 
of this construct, the completely internal distribution of 
fluorescence in 27% of cells expressing these constructs, 
and the minor component (16% of the whole cell ROI 
NFRET) contributed from the peripheral ROI lead us 
to conclude that the NFRET signal was mainly due to 
assembled intracellular mGAT1
565XFP
566CT rather than 
plasma  membrane–inserted  transporters,  even  in  the 
peripheral ROI. The ratio of the mean NFRET for   
all  pixels  in  the  peripheral  ROI  compared  with  the   
perinuclear ROI was 0.99. mGAT1
565XFP
566CT NFRET   Moss et al. 503
pressing  mGAT1
570XFP
571CT  was  similar  between  the 
peripheral and perinuclear ROIs (ratio 1.0). Analysis of 
the NFRET distributions for each ROI determined that 
all were best fit with two Gaussians (Fig. 10, G and H). 
However, in the periphery, the two components did not 
appear to describe the same populations reported by 
the  components  of  the  other  ROIs.  The  mean  amp-
litude of the major peripheral NFRET component (98% 
of the signal) lay approximately halfway between the 
amplitudes of the two NFRET components of the peri-
nuclear, intracellular, or whole cell ROIs. We suggest 
that two Gaussian components merged into one with an 
intermediate  NFRET  amplitude  in  the  periphery  be-
cause the populations mix at a level too fine to resolve 
in a 69-nm
2 pixel (see Appendix). The second compo-
nent  of  the  mGAT1
570XFP
571CT  peripheral  NFRET 
signal had a mean amplitude (0.29 ± 0.09) twice that 
observed for the second Gaussian component of the 
perinuclear ROI NFRET (Fig. 10, G and H). Although 
contributing only a small fraction (2.3%) of the total sig-
nal for the peripheral ROI, the ratio of mean NFRET amp-
litude of this component versus the second component 
distributions were best fit with two Gaussians in all ROIs 
examined (Fig. 10, C and D). In the peripheral and 
perinuclear ROIs, the two subpopulations contributed 
approximately equally to the total NFRET signal. In 
the intracellular ROI, the lower mean NFRET signal 
predominated.
The mean NFRET amplitude from mGAT1
570XFP
571CT-
expressing cells (Fig. 10, E and F, and Table I) was less 
than  that  from  those  expressing  mGAT1
565XFP
566CT. 
This probably arose in part from the increased fluoro-
phore separation in this construct. The XFP moiety is 
fused five residues more distal from the end of the TM12 
helix in the mGAT1
570XFP
571CT constructs. Exact inter-
molecular distances cannot be calculated from FRET 
efficiencies of proteins fused to GFP derivatives (Rizzo 
et al., 2006). However, side-by-side FRET efficiency 
calculations (using Eq. 4) suggested that in the perinu-
clear ROIs, the apparent fluorophore separation in 
mGAT1
570XFP
571CT oligomers (E = 7.9 ± 1.9%) is on av-
erage  1.25-fold  greater  than  in  mGAT1
565XFP
566CT 
oligomers (E = 25 ± 3.5%). As for mGAT1
565XFP
566CT, 
the mean NFRET amplitude from all pixels in cells ex-
Figure 9.  Pixel-by-pixel quantification of sensitized emission FRET between mGAT1XFP45. (A; from left to right) mGAT1CFP45 fluo-
rescence and mGAT1YFP45 fluorescence (calibration bars, ACUs), ROIs used to determine NFRET (color coding as in Fig. 8), and the 
NFRET image (color calibration bar, NFRET × 100) of the same cell. Pixels with amplitude below threshold are shaded gray. Bars, 
10 µm. (B) Box plots displaying NFRET for all pixels in each ROI of cells expressing mGAT1XFP45. The box, whiskers, and other data 
points are represented as in Fig. 7 B. Box plots for each ROI are colored according to the code in A (ROI), and the intracellular data 
are colored blue. (C) Table of results for mGAT1XFP45 transfections displaying the mean of each Gaussian component of the summed 
fit of the distributions in Fig. 8 D and the percentage of the pixels that comprise each component. (D) Distributions of NFRET signal 
amplitude per pixel for each ROI (bin width, 0.02) from mGAT1XFP45-expressing cells. The individual components and their sum are 
shown as dashed and solid lines, respectively.504 NFRET resolves GAT1 oligomerization state and anchoring
Figure 10.  Pixel-by-pixel quantification of sensitized emission FRET between mGAT1
565XFP
566CT and mGAT1
570XFP
571CT. (A; from 
left to right) mGAT1
565CFP
566CT fluorescence and mGAT1
565YFP
566CT fluorescence (calibration bars, ACUs), ROIs used to determine 
NFRET (color coding as in Fig. 8), and the NFRET image (color calibration bar, NFRET × 100) of the same cell. Pixels with signal 
amplitude below threshold are shaded gray. Bars, 10 µm. (B) Box plots displaying NFRET for all pixels in each ROI of cells expressing 
mGAT1
565XFP
566CT. The box, whiskers, and other data points are represented as in Fig. 7 B. Box plots for each ROI are colored accord-
ing to the code in Fig. 8 A (ROI), and the intracellular data are colored blue. (C) Table of results for mGAT1
565XFP
566CT transfections 
displaying the mean of each Gaussian component of the summed fit of the distributions in D and the percentage of the pixels compris-
ing each component. (D) Distributions of NFRET signal amplitude per pixel for each ROI (bin width, 0.02) from mGAT1
565XFP
566CT-
expressing cells. The individual components and the sum of the fit are shown as dashed and solid lines, respectively. (E) Representative 
fluorescence images of mGAT1
570XFP
571CT-expressing N2a cells, the regions of interest, and corresponding NFRET image. Calibration 
and color coding are as for Fig. 8 A. (F) Box plots displaying NFRET for all pixels in each ROI of cells expressing mGAT1
570XFP
571CT.   Moss et al. 505
of the perinuclear or intracellular ROIs (2.1 and 1.7, re-
spectively)  resembled  that  of  the  highest-amplitude 
component  of  mGAT1XFP*  or  mGAT1XFP8  NFRET 
(Fig.  8).  The  small  but  measureable  high-amplitude 
NFRET component in the mGAT1
570XFP
571CT periph-
eral  NFRET  signal  presumably  reflects  its  impaired 
plasma membrane insertion, as determined by GABA 
uptake assays (Fig. 5 B), and is also consistent with the 
observation  that  mGAT1
570XFP
571CT  functions  better 
than mGAT1
565XFP
566CT (Fig. 5 B).
mGAT1
577XFP
578CT, which exhibited almost wild-type 
function  (Fig.  5,  B  and  C),  displayed  strong  mean 
NFRET for all pixels in the peripheral ROI, 1.7-fold 
greater  than  that  observed  in  the  perinuclear  ROI 
(Fig. 11, A and B, and Table I). This NFRET amplitude 
was  1.5-  to  1.8-fold  stronger  than  that  for  the  mean 
NFRET amplitude from all pixels in the peripheral ROI 
of mGAT1XFP*- or mGAT1XFP8-expressing cells (Fig. 8). 
As  observed  for  those  other  wild-type  functioning   
C-terminal fusions, the NFRET amplitude in the intra-
cellular and whole cell ROIs was significantly less. The 
NFRET distributions from intracellular and perinuclear 
ROIs of mGAT1
577XFP
578CT-expressing N2a cells could 
be fitted with two Gaussians with low and intermediate 
mean NFRET amplitudes, the latter component provid-
ing approximately two thirds of the NFRET signal in 
the perinuclear ROI (Fig. 11, C and D). Importantly, in 
the peripheral ROI, a third Gaussian component ap-
peared;  this  component  was  also  detectable  in  the 
whole cell ROI (Fig. 11 D). This component had a mean 
NFRET amplitude (0.31 ± 0.04) twice that of the sec-
ond  intermediate-amplitude  NFRET  component  and 
comprised 30% of the peripheral NFRET signal. The 
relative distribution of transporter subpopulations for 
this  construct,  as  determined  by  the  components  of 
NFRET in each ROI, resembled that for the wild-type 
Color coding and data are represented as in B. (G) Table of results for mGAT1
570XFP
571CT transfections displaying the mean of 
each Gaussian component of the summed fit of the distributions in H and the percentage of the pixels that comprise each component. 
(H) Distributions of NFRET signal amplitude per pixel for each ROI (bin width, 0.02) from mGAT1
570XFP
571CT-expressing cells. The 
individual components and their sum are shown as dashed and solid lines, respectively.
 
Figure  11.  Pixel-by-pixel  quantification  of  sensitized  emission  FRET  between  mGAT1
577XFP
578CT.  (A;  from  left  to  right) 
mGAT1
577CFP
578CT fluorescence and mGAT1
577YFP
578CT fluorescence (calibration bars, ACUs), ROIs used to determine NFRET (color 
coding as in Fig. 8), and the NFRET image (color calibration bar, NFRET × 100) of the same cell. Pixels with amplitude below threshold 
are shaded gray. Bars, 10 µm. (B) Box plots displaying NFRET for all pixels in each ROI of cells expressing mGAT1
577XFP
578CT. The box, 
whiskers, and other data points are represented as in Fig. 7 B. Box plots for each ROI are colored according to the code in A (ROI), and 
the intracellular data are colored blue. (C) Table of results for mGAT1
577XFP
578CT transfections displaying the mean of each Gaussian 
component of the summed fit of the distributions in D and the percentage of the pixels that comprise each component. (D) Distribu-
tions of NFRET signal amplitude per pixel for each ROI (bin width, 0.02) from mGAT1
577XFP
578CT-expressing cells. The individual 
components and the sum of the fit are shown as dashed and solid lines, respectively.506 NFRET resolves GAT1 oligomerization state and anchoring
that the mean Pearson product-moment correlation (r) 
for the colocalization of the CFP and YFP signals coex-
pressing mGAT1CFP8 and mGAT1YFP8 was 0.9 ± 0.01 
(n = 31 cells) (not depicted). Colocalization analysis of 
the  YFP  fluorescence  and  the  nF  signal  in  the  same 
group of cells reported that r = 0.5 ± 0.05 (Fig. 12 B). 
The square of r indicated that 25 ± 1.5% of the variance 
of nF in mGAT1XFP8-expressing cells is associated with 
changes in YFP intensity. When the relative contribu-
tions of the CFP and YFP intensities to the FRET signal 
in each pixel were normalized to generate the NRET 
images from the same cells, r = 0.01 ± 0.05 for IYFP versus 
NFRET colocalization (Fig. 12 B). This indicated that 
the normalization step in NFRET corrects for the influ-
ence  of  IYFP  variance.  One  concludes  that  calculated 
NFRET was not artificially large due to high local IYFP in 
some ROIs.
functioning mGAT1XFP* and mGAT1XFP8 constructs 
(Fig. 8).
High NFRET in the peripheral ROI is independent  
of variance of YFP intensity
We examined whether high NFRET amplitudes mea-
sured in this study, particularly those at the periphery of 
cells expressing the wild-type functioning mGAT1XFP8 
constructs, were large because of high local concentra-
tions of YFP-tagged protomers in some domains. Line 
profile plots through cells expressing mGAT1XFP8 em-
phasized that the pixels with the greatest YFP signal in-
tensity were usually located at the periphery of the cell 
(Fig. 12 A), as were the pixels with the highest amp-
litude net FRET (nF) or NFRET. We measured the colo-
calization of the YFP signal with both the nF signal and 
the NFRET signals. As a positive control, we determined 
Figure 12.  Colocalization of 
IYFP with net FRET and NFRET 
signals. (A) Line profile analy-
sis  of  YFP  fluorescence.  nF 
and  NFRET  measurements 
through  the  mGAT1XFP8-
expressing cell in B illustrate 
the peripheral localization of 
the signals for all parameters. 
(B) Images report the colo-
calization  of  YFP-expressing 
pixels with the nF or NFRET 
signals. Correlation of the nF 
or  NFRET  signal  with  YFP 
intensity is plotted in the bot-
tom  panels.  Note  that  the 
normalization routine allows 
NFRET to measure FRET in-
dependently of YFP intensity.  Moss et al. 507
NFRET amplitude percentile groups (Fig. 13 A; look-up 
table in far right panel of Fig. 13 B). The pixels con-
tained within each bin or group are highlighted with 
the same color in the NFRET image (Fig. 13 B). We cal-
culated each pixel’s percent radial distance from the 
cell’s center to the cell periphery. We analyzed the local-
ization of NFRET amplitude for three representative 
constructs: mGAT1XFP8, which oligomerized efficiently 
as determined by acceptor photobleach and sensitized 
FRET analysis and functioned like wild-type nonlabeled 
mGAT1;  mGAT1
565XFP
566CT,  which  showed  strong 
FRET but compromised function; and mGAT1XFP45, 
which demonstrated weak function and weak FRET. The 
results of the analyses plotted in Fig. 13 C determined 
Radial distance analysis of NFRET signal amplitude 
correlates to functional phenotype
The presence of the three NFRET components from 
only the fluorescent mGAT1 constructs with wild-type–
like function suggested that one component arose from 
a mechanism that operates only in the cell periphery 
for mGAT1 oligomers, which are appropriately inserted 
into the plasma membrane. Apparently, this plasma 
membrane–associated  component  is  also  the  compo-
nent with the highest NFRET amplitude. We have al-
ready qualitatively observed that the largest amplitude 
NFRET  signal  occurred  in  the  periphery  of  the  cell   
(Fig. 12 A). As described in Materials and methods, we 
further analyzed NFRET images by grouping pixels into 
Figure 13.  Radial analysis of NFRET amplitude distributions. (A) Exemplar NFRET distribution with bins colored by percentile NFRET 
amplitude. The colors of the pixels in each bin were applied to the NFRET images as displayed in B. The right-hand panel displays how 
the radius of each pixel from the cell’s center of mass was determined (see Materials and methods). The indentation shows that the 
analysis provides reliable data despite dark areas such as the nucleus or, in some cases, irregular-shaped cells. (B) NFRET images colored 
by NFRET amplitude percentile for exemplar cells expressing the wild-type–like functioning mGAT1XFP8, efficiently oligomerized but 
intracellularly retained mGAT1
565XFP
566CT, and the poorly oligomerized and predominantly intracellular mGAT1XFP45. The color 
code for the NFRET amplitude by percentile is at the right. (C) Plot of the mean distance from the center of mass of each percentile 
group for each construct. Each construct displayed a unique profile. Y error bars, SEM; x bars, size of each percentile group.508 NFRET resolves GAT1 oligomerization state and anchoring
uptake  levels).  For  these  constructs,  the  peripheral 
ROI  NFRET  distributions  could  be  fitted  to  three 
Gaussian components, and we have presented analyses 
that the highest-amplitude component arises from plasma 
membrane molecules. On the other hand, constructs 
with  significantly  reduced  substrate  transport  rates 
(corresponding to reduced plasma membrane inser-
tion) relative to wild-type GAT1 displayed peripheral 
ROI NFRET distributions comprising only two compo-
nents (Fig. 14 B). The data suggest a threshold effect: 
if the peripheral NFRET distribution includes ≥30% 
of  the  high-amplitude  NFRET  component,  fluores-
cent mGAT1 molecules exhibit wild-type–like func-
tion (Fig. 14 B).
that the NFRET signals from pixels in cells expressing 
mGAT1XFP8 were the most peripherally located; the 
minimum percent distance from the center of mass for 
any NFRET amplitude percentile group was >85%. The 
pixels in the top fifth percentile of NFRET amplitude 
for mGAT1XFP8 were located a mean distance of 93% 
of the total radius from the center to mass to the edge 
of the cell, quantifying the statement that the highest-
amplitude NFRET pixels were also the most peripher-
ally located in the cell. Overall, the localization of NFRET 
signals  of  all  amplitudes  from  pixels  expressing 
mGAT1
565XFP
566CT trended toward the cell periphery 
rather than the center of mass, but significantly less 
so  than  from  mGAT1XFP8.  The  trend  followed  a   
U-shaped pattern, with the bottom and top 20% NFRET 
pixel amplitudes being the most peripherally located 
(>70%), and the medium amplitude NFRET pixels 
residing in more intracellular locations. Localization 
of mGAT1XFP45 pixels that reported positive NFRET 
trended to more random distributions with increas-
ing NFRET amplitude.
Correlation between function of fluorescent mGAT1 
transporters and their NFRET properties
Fig. 14 provides two ways to summarize the trends in 
NFRET and their relationship to function ([
3H]GABA 
uptake) of mGAT1 constructs. Both panels of Fig. 14 
highlight the set of three correctly oligomerized, cor-
rectly  trafficked,  and  correctly  functioning  fluores-
cent  constructs:  mGAT1XFP*,  mGAT1XFP8,  and 
mGAT
577XFP
578CT. In Fig. 14 A, we compare the function 
of  each  fluorescent  construct  (relative  to  nontagged 
wild-type mGAT1) versus the ratio of peripheral to peri-
nuclear NFRET. The peripheral/perinuclear ratio was 
calculated from the mean NFRET for all pixels in each 
ROI. In this analysis, the fluorescent transporters could 
be classified into three groups:
(1) The three constructs with >75% wild-type func-
tion, as determined by [
3H]GABA uptake, displayed a 
peripheral/perinuclear NFRET ratio ≥1.4.
(2) Constructs with compromised function (30–65% 
wild-type [
3H]GABA uptake) demonstrated efficient 
oligomerization as determined by FRET quantifica-
tion, but less efficient plasma membrane insertion, 
indicated  by  peripheral/perinuclear  NFRET  ratios 
close to 1.0.
(3)  Represented  by  mGAT1XFP45,  the  constructs 
that display <30% of wild type function, limited oligo-
merization, and poor trafficking properties expressed a 
peripheral/perinuclear NFRET ratio of 0.1.
Wild-type functioning fluorescent transporters could 
therefore be clearly distinguished from constructs with 
poor  oligomerization  and/or  trafficking:  the  former 
possess a peripheral/perinuclear NFRET ratio ≥1.4.
Fig.  14  B  presents  an  additional  hallmark  of  the 
three well-functioning constructs (as shown by [
3H]GABA 
Figure 14.  The relationship between transporter function and 
NFRET.  (A)  Scatter  plot  of  the  ratio  and  mean  (peripheral 
NFRET)/(perinuclear NFRET) for all pixels in the ROIs versus 
the percent function of each construct as compared with nonfluo-
rescent wild-type mGAT1 in [
3H]GABA uptake assays. Data points 
for constructs are individually labeled and omit the mGAT1 prefix, 
which is common to all. Constructs with ≥75% wild-type function 
are represented by solid symbols. Constructs that showed ≤65% 
wild-type function but good whole cell NFRET are represented 
by half-filled symbols. mGAT1XFP45, which demonstrated poor 
function and poor whole cell NFRET, is represented by an open 
symbol. (B) The proportions of each Gaussian component of the 
total peripheral ROI NFRET signal for each construct are plotted 
in stacked columns. Each column represents a single construct 
design and appears on the x axis at the percentage of wild-type 
[
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analyzed pixels was best fit by two Gaussian components, 
with  mean  NFRET  of  0.19  (representing  75%  of  all 
FRETing pixels) and 0.28 (Fig. 15 C).
C-terminal PDZ interactions are required to produce 
NFRET distributions comprising three  
Gaussian components
The PDZ type II–interacting domain at the distal C ter-
minus of mGAT1 is necessary for at least two important 
transporter interactions in the cell periphery: with the 
exocyst complex (Farhan et al., 2004) and with the actin 
cytoskeleton (Imoukhuede et al., 2009). To determine 
whether an interaction of the C-terminal mGAT1 PDZ-
interaction domain produced the observed third, high 
NFRET component in peripheral ROI NFRET distribu-
tions,  we  coexpressed  mGAT10CFP  and  mGAT10YFP 
and examined the resulting subcellular NFRET profiles. 
As demonstrated earlier (Fig. 4 A), this construct design 
had  compromised  function.  This  occurs  because  the 
XFP moiety blocks access to the endogenous PDZ-inter-
action domain of mGAT1 (Imoukhuede et al., 2009). 
Fig. 16 A displays representative images of the donor 
and acceptor fluorescence in an mGAT10XFP-express-
ing cell together with the defined ROIs and calculated 
NFRET image. The ratio of mean NFRET amplitude for 
the  peripheral  versus  the  perinuclear  regions  for  63 
cells expressing mGAT10XFP was 0.9 (Fig. 16 B and Ta-
ble I), in contrast to 1.4 observed above for mGAT1XFP8 
(Fig. 8 F and Table I). Furthermore, the NFRET distri-
butions for all ROIs from mGAT10XFP-expressing cells 
were best fit by two Gaussian components. This indi-
cated that mGAT1 transporters must possess a func-
tional C-terminal PDZ-interacting domain to exhibit 
Nicotinic receptors also display a two-component  
NFRET distribution
Data presented to this point indicate that mGAT1, a mem-
brane protein, displays only a two-component NFRET 
distribution if its oligomers are not inserted into the 
plasma  membrane  at  normal  wild-type  levels.  We  as-
sessed whether this conclusion holds for another mem-
brane protein whose oligomerization has been studied 
in our laboratory in the N2a system: the heteropentam-
eric mouse 42 nAChR (Nashmi et al., 2003; Drenan 
et al., 2008; Son et al., 2009). Previous data indicate that 
42 receptors are retained to a large extent in intracel-
lular  compartments  (Nashmi  et  al.,  2003;  Kuryatov   
et al., 2005; Sallette et al., 2005; Drenan et al., 2008; Son 
et al., 2009).
As with previous studies of this channel expressed in 
N2a cells (Drenan et al., 2008; Son et al., 2009), HEK 
293  cells  (Nashmi  et  al.,  2003),  transfected  neurons 
(Nashmi et al., 2003; Khakh et al., 2005), and 4YFP 
knock-in mice (Nashmi et al., 2007), the fluorescence of 
both 4YFP and 2CFP nAChR subunits appeared evenly 
throughout the ER of N2a cells (Fig. 13 A), with a high 
degree  of  colocalization  (Pearson  product-moment   
correlation coefficient: r = 0.9 ± 0.02; n = 11 cells) (not 
depicted). As described above (Fig. 7), the even fluores-
cence distribution throughout the cell provided only a 
single ROI per cell for this transfection: the ROI encom-
passed the entire cell without the nucleus. This was de-
termined by the pixels exhibiting YFP fluorescence.
Robust  FRET  was  observed  throughout  cells  coex-
pressing  4YFP2CFP  nAChR  subunits;  the  mean 
NFRET for all pixels was 0.20 (Fig. 15, A and B, and   
Table I). The distribution of NFRET amplitudes for all 
Figure  15.  Pixel-by-pixel 
quantification  of  sensi-
tized  emission  FRET  within   
4YFP2CFP  nAChRs.  (A; 
from left to right) Panels dis-
play an N2a cell coexpressing   
2CFP  and  4YFP  nAChR 
subunits with nonfluorescent 
wild-type  mGAT1  (calibra-
tion bars, ACUs). The whole 
cell ROI in which FRET was 
quantified  is  displayed  in 
black in the third panel. The 
fourth  panel  displays  the 
NFRET  image  (calibration 
bar,  NFRET  ×  100).  Pixels 
with signal amplitude below 
threshold  are  shaded  gray. 
Bars, 10 µM. (B) Box plot dis-
playing the range of NFRET 
detected from 4YFP2CFP-
coexpressing  N2a  cells.  The 
box, whiskers, and other data points are represented as in Fig. 7 B. The mean and median NFRET amplitudes for all pixels in each ROI 
are displayed in Table I. (C) Distribution of NFRET signal amplitudes per pixel (bin width, 0.02). The histogram was fit to two Gaussian 
distributions. The individual components are shown as dashed lines, and the sum of the fit is shown as a solid line. The inset table reports 
the mean NFRET amplitude of each component and the percentage of the total pixels that comprise each component.510 NFRET resolves GAT1 oligomerization state and anchoring
NFRET signal (Fig. 17, C and E). The intracellular and 
perinuclear ROIs were best fit with two Gaussian compo-
nents (Fig. 17 C). Treatment of mGATXFP8-expressing 
cells with latrunculin B produced NFRET distributions 
from whole cell and peripheral ROIs that were best fit with 
two Gaussian components, similar to data for the fluores-
cent mGAT1 constructs with less than wild-type function 
(Fig. 17 D). Latrunculin B treatment therefore demon-
strated that the polymerized actin cytoskeleton was re-
quired for the PDZ-interacting domain–mediated high 
NFRET component in the cell periphery.
Interestingly, the perinuclear ROI of latrunculin B–
treated cells was best fit by three Gaussian components 
(Fig. 17 D). A three-component perinuclear distribu-
tion was not found under other conditions in this study. 
The amplitude of the third component was equivalent 
to that seen in the periphery of nontreated cells and 
comprised a similar proportion of the total NFRET dis-
tribution in that ROI (30%; Fig. 17 E). This was not 
observed  in  the  perinuclear  ROI  of  mGAT10XFP-ex-
pressing cells, suggesting that the intact PDZ-interact-
ing domain of mGAT1XFP8 plays a role.
the third high-amplitude NFRET component in the 
cell periphery.
PDZ-mediated tethering to the cytoskeleton locates third 
high-amplitude NFRET component in the cell periphery
A PDZ domain interaction occurs in the ezrin-mediated 
tethering of mGAT1 oligomers to the actin cytoskeleton 
(Imoukhuede et al., 2009). We therefore investigated 
whether an intact cytoskeleton is required for the ob-
served high NFRET component at the cell periphery.
We transfected N2a cells with the mGAT1XFP8 con-
structs and in half of the transfected dishes depolymerized 
the actin cytoskeleton with 5 µM latrunculin B (Fig. 17). 
As previously observed, mGAT1XFP8 showed detectable 
NFRET in all ROIs. The ratio of mean peripheral to peri-
nuclear NFRET amplitude was 1.4 (Fig. 17 B, left; 67 cells, 
4.7 and 1.8 × 10
5 pixels, respectively). 5 µM latrunculin B 
decreased this ratio to 0.9 (Fig. 17 B, right). The NFRET 
distributions for nontreated mGAT1XFP8-expressing N2a 
cells were fit with three Gaussian components in the whole 
cell and peripheral ROIs, with the highest mean amp-
litude NFRET component comprising 30% of the total 
Figure 16.  Pixel-by-pixel quantification of sensitized emission FRET between mGAT10XFP constructs. (A; from left to right) mGAT10CFP 
fluorescence and mGAT10YFP fluorescence (calibration bars, ACUs), ROIs used to determine NFRET (color coding as in Fig. 8), and 
the NFRET image (color calibration bar, NFRET × 100) of the same cell. Pixels with amplitude below threshold are shaded gray. Bars, 
10 µm. (B) Box plots displaying NFRET for all pixels in each ROI of cells expressing mGAT10XFP. The box, whiskers, and other data 
points are represented as in Fig. 7 B. Box plots for each ROI are colored according to the code in A (ROI), and the intracellular data are 
colored blue. (C) Table of results of mGAT10XFP transfections displaying the mean of each Gaussian component of the summed fit of 
the distributions in D and the percentage of the pixels that each component represents. (D) Distributions of NFRET signal amplitude 
per pixel for each ROI (bin width, 0.02) from mGAT10XFP-expressing cells. The individual components and the sum of the fit are shown 
as dashed and solid lines, respectively.  Moss et al. 511
tation was introduced into every construct (Zacharias 
et al., 2002).
(2) The GAT1 protomers might have no tendency to 
associate directly and are distributed randomly in cellu-
lar membranes, with FRET occurring through stochas-
tic interactions in domains where the protomers are 
clustered  at  high  density.  Thus,  controlling  for  colli-
sional FRET is critical (Blackman et al., 1998; Tadross 
et al., 2009). In this paper, we believe there is minimum 
contribution from this scenario: at the expression levels 
used in this study, for constructs that exhibit >25% wild-
type mGAT1 function, very little of the total NFRET 
arises from stochastic interactions of high local concen-
trations of mGAT1XFP monomers. To support this 
statement, we invoke the examples of the mGAT1XFP45 
and the XFP15mGAT1 constructs. Neither of these ex-
hibited FRET by the acceptor photobleach method, 
despite extensive colocalization of CFP- and YFP-tagged 
mGAT1 protomers. In the pixel-by-pixel analysis of sen-
sitized mGAT1XFP45 NFRET, some positively FRETing 
pixels  were  observed.  However,  a  fraction  of  the 
mGAT1XFP45 FRETing pixels is also expected to repre-
sent the small proportion of mGAT1XFP45 protomers 
that was able to assemble as functional oligomers and 
traffic  to  the  plasma  membrane,  as  reported  by  the 
[
3H]GABA uptake assays. Oligomerization is a prereq-
uisite for ER export of the SLC6 family of transporters 
(Farhan et al., 2006; Bartholomäus et al., 2008); there-
fore, the functional mGAT1XFP45 construct in the plasma 
membrane must be at least a dimer. In summary, we be-
lieve  that  donor–acceptor  excitations  are  rare  occur-
rences unless the fluorophores are part of a biologically 
functional oligomeric complex.
(3) Therefore, in all likelihood, mGAT1 dimers and 
possibly higher-order oligomers (e.g., dimers of dimers 
or trimers of dimers) assemble. Even if mGAT1 can only 
maximally oligomerize as dimers, a high concentration 
of dimers in a particular domain can result in inter-di-
mer energy transfer, producing NFRET. In our linear 
expression system, we expect minimal contributions of 
inter-oligomer proximity to the measured NFRET amp-
litude, for the same reason that we expect little contri-
bution to the NFRET amplitude from random proximity 
of donor- and acceptor-tagged mGAT1 monomers.
The basic oligomeric unit of mGAT1 is a dimer, and an 
atomic-scale structure is available for dimers of a homolo-
gous transporter (Yamashita et al., 2005). Features of this 
dimer render it unlikely that a trimer would form, so that 
the simplest likely high-order oligomer is a dimer of 
dimers. The Appendix presents assumptions and calcu-
lations analyzing the FRET properties of dimers and 
tetramers. The results are consistent with the idea that 
the first and second Gaussian components of the all-pixel 
mGAT1 NFRET amplitude distributions represent the 
dimer and a high-order oligomerization state (probably 
a square or rhomboid tetramer), respectively.
D I S C U S S I O N
FRET  between  GFP  variant-tagged  molecules  reports 
separations of <100 Å. In live cells, this distance can be 
achieved  only  by  directly  interacting  proteins  (Sekar 
and  Periasamy,  2003).  FRET  has  previously  demon-
strated  that  GAT1  and  other  SLC6  neurotransmitter 
transporters oligomerize (Soragna et al., 2005; Farhan 
et al., 2006; Bartholomäus et al., 2008). The dimeriza-
tion of transporter protomers is required for efficient 
export from the ER (Farhan et al., 2006). Acceptor pho-
tobleach FRET gave good whole cell measurements of 
mGAT1 assembly but did not differentiate between fluo-
rescent constructs with wild-type–like or compromised 
plasma membrane insertion.
Pixel-by-pixel analysis of NFRET allowed the accurate 
measurement of FRET in various subcellular regions, 
and the individual components of NFRET distributions 
in each ROI correlate with functional phenotype. Ana-
lyzing each construct’s number of Gaussian compo-
nents in an NFRET distribution overcame complications 
from the fact that each construct has a unique separa-
tion and/or orientation between fluorophores. We sim-
ply assumed that the rank order of NFRET distribution 
components arises from mechanisms that are common 
across the entire set of constructs.
We observed at least two oligomerization states of the 
mGAT1 transporter in the basal state (in the absence of 
substrate). These oligomerization states probably bear 
no relation to the time-resolved conformational states 
that occur during the permeation cycle for the SLC6 
neurotransmitter transporter family (Mager et al., 1994; 
Li et al., 2000; Loo et al., 2000; Kanner, 2003; Rudnick, 
2006). Rather, they represent the basic oligomer formed 
by mGAT1 protomers and high-order complexes of 
basic mGAT1 oligomers (e.g., dimers of dimers). In 
intracellular organelles (e.g., ER or Golgi), these two 
oligomer types are represented by two Gaussian compo-
nents of the NFRET distribution. A third mGAT1 oligo-
mer exists in the periphery of cells expressing fluorescent 
transporters that are functionally indistinguishable from 
the nontagged wild-type mGAT1. This species is repre-
sented in NFRET distributions by a third Gaussian com-
ponent that always possesses the highest mean amplitude 
of the three. If the high-amplitude component accounts 
for 30% of the total NFRET distribution, the fluores-
cent mGAT1 construct functions with >75% of the wild-
type rate.
Oligomeric states may generate the components in the 
Gaussian fits to mGAT1 NFRET distributions
We consider three explanations for the measured NFRET 
between fluorescently tagged GAT1 protomers.
(1) The XFPs themselves might drive apparent oligo-
merization of the fused protein of interest. We rule 
out this possibility because the monomeric A206K mu-512 NFRET resolves GAT1 oligomerization state and anchoring
Figure 17.  Pixel-by-pixel quantification of sensitized emission FRET from mGAT1XFP8 when cells are treated with 5 µM latrunculin B. 
(A; top row, from left to right) mGAT1CFP8 fluorescence and mGAT1YFP8 fluorescence (calibration bars, ACUs), ROIs used to de-
termine NFRET (color coding as in Fig. 8), and the NFRET image (color calibration bar, NFRET × 100) of the same cell. (Bottom row) 
mGAT1XFP8-expressing cells after 1-h treatment with 5 µM latrunculin B. Bars, 10 µm. (B) Box plots displaying NFRET for all pixels in 
each ROI of cells expressing mGAT1XFP8 (left) and mGAT1XFP8 treated with latrunculin B (right). The box, whiskers, and other data 
points are represented as in Fig. 7 B. Box plots for each ROI are colored according to the code in A (ROI), and the intracellular data are 
colored blue. (C) Distributions of NFRET signal amplitude per pixel for each ROI (bin width, 0.02) from mGAT1XFP8-expressing cells. 
The individual components and the sum of the fit are shown as dashed and solid lines, respectively. (D) Distributions of NFRET signal 
amplitude per pixel for each ROI (bin width, 0.02) from mGAT1XFP8-expressing cells plus latrunculin B. The individual components   Moss et al. 513
When NFRET distributions are fit to three Gaussian 
components, the highest NFRET component reports the 
specific locations of mGAT1 C-terminal PDZ interactions
The  peripheral  ROI  includes  both  the  plasma  mem-
brane  and  the  immediately  adjacent  intracellular  re-
gion. Several of the constructs display high fluorescence 
in the cell periphery but have major functional deficits, 
presumably owing to poor plasma membrane insertion. 
FRET determined that these constructs with trafficking 
deficits efficiently oligomerized, but the ratio (periph-
eral NFRET/perinuclear NFRET) was 1.0 (in contrast 
to the value of 1.4 for the best-inserted constructs) 
(Fig. 14 A). Furthermore, both the peripheral and peri-
nuclear NFRET distributions were fit by two Gaussian 
components, again in contrast to the three components 
for the best-inserted constructs (Figs. 9 D, 10, D and H, 
and 16 D). The data are consistent with the idea that 
well-inserted plasma membrane transporters display an 
additional component with higher mean NFRET ampli-
tude comprising 30% of the NFRET distribution.
In the basal state, one third of the acutely recycling 
pool of GAT1 transporters resides in the plasma mem-
brane (Wang and Quick, 2005). This fraction resembles 
the proportion of the total peripheral NFRET repre-
sented by the highest-amplitude component in the cell 
periphery.  The  radial  analysis  of  NFRET  amplitudes 
(Fig. 13) suggests that the highest-amplitude compo-
nent of peripheral NFRET represents most of the fluo-
rescent  GAT1  complexes  inserted  into  the  plasma 
membrane. Furthermore, the presence of this compo-
nent and the proportion of the total NFRET that it rep-
resents serve as an indicator of transporter function; 
the assay could help in the future design of other fluo-
rescent transporter constructs. Judging the generality 
of the pixel-by-pixel method will require examination 
with additional classes of transmembrane proteins. We 
demonstrate here that 42 nAChRs predominantly re-
side  in  intracellular  compartments  in  the  basal  state 
and have NFRET distributions comprising two Gaussian 
components (Fig. 12). These two components may rep-
resent the two possible functional stoichiometries of 4 
and  2  nAChR  subunits,  (4)3(2)2  and  (4)2(2)3 
(Son  et  al.,  2009).  Moreover,  independent  investiga-
tions suggested the geometry of G protein–coupled 
receptor oligomers by fitting FRET distributions with 
Gaussian components (Raicu et al., 2009).
We determined that the physical origin of the third 
high NFRET component amplitude for mGAT1 oligo-
mers closely associated with the surface membrane re-
quires (a) that the fluorescent mGAT1 construct possess 
an intact PDZ type II–interaction domain at the distal C 
terminus, and (b) that the mGAT1 C terminus be teth-
ered to the actin cytoskeleton via this domain (Fig. 16). 
mGAT10XFP  does  not  interact  with  PDZ  proteins 
(Imoukhuede et al., 2009), limiting its presentation at 
the plasma membrane (Chiu et al., 2002), probably 
because of compromised interaction with the exocyst   
(Farhan et al., 2004). mGAT10XFP NFRET distributions 
are always fit to only two Gaussian components in any 
ROI  (Fig.  16).  Furthermore,  the  NFRET  distributions 
from cells expressing a different class of plasma mem-
brane oligomers, the 42 nAChR, which does not make 
direct PDZ-mediated interactions in the cell periphery, 
can be fit to only two components (Fig. 15). In N2a cells 
expressing mGAT1XFP8, which has a functional PDZ-in-
teraction domain, actin depolymerization via latrunculin 
B eliminated the third high-amplitude NFRET compo-
nent present in the peripheral ROI (Fig. 17). Collectively, 
these results support the view that, if the C terminus of 
mGAT1 is tethered to an intact cytoskeleton via a func-
tional  PDZ-interaction  domain,  one  observes  three 
NFRET components in the periphery. We suggest that 
this interaction produces the highest mean amplitude 
NFRET component of the three, and thus this compo-
nent can be used as a marker of this intracellular event. 
Presumably, the fluorophores located at the very distal C 
termini of mGAT1XFP8 oligomers are constrained in a 
way that increases FRET. If the tethering restricts the mo-
tion of the C terminus without changing the average flu-
orophore separation, this might actually decrease FRET 
(Lakowicz, 2006b). On the other hand, if the tethering 
draws the C termini closer together, or restricts the ro-
tation of the fluorescent moieties to angles that have 
favorable dipole–dipole coupling, this would markedly 
increase FRET efficiency.
In  this  investigation,  latrunculin  B  treatment  of 
mGAT1XFP8-expressing cells was the only manipulation 
causing three NFRET components in an intracellular ROI. 
The amplitude and proportion of the total NFRET for the 
perinuclear ROI of the third component resembled that 
observed in the periphery of untreated cells. We suspect 
that the perinuclear high-FRET component for the latrun-
culin treatment arose from a pathological concentration 
of mGAT1 oligomers in perinuclear organelles. In addi-
tion to decoupling membrane-resident mGAT1 from the 
actin cytoskeleton, actin depolymerization disrupts nor-
mal  endocytosis  and  endosomal  sorting  and  recycling 
(Roux et al., 2006; Gauthier et al., 2007; Doherty and 
McMahon, 2009; Morel et al., 2009). Significant slowing 
of actin-dependent endocytic traffic relative to overall 
mGAT1 insertion rates during latrunculin B incubation 
would explain our previously observed increases in 
[
3H]GABA uptake for both mGAT1YFP8 or mGAT10GFP 
(Imoukhuede et al., 2009). Additionally, PDZ-associated 
and the sum of the fit are shown as dashed and solid lines, respectively. (E) Table of results for mGAT1XFP8 transfections before and 
after latrunculin B treatment displaying the mean of each Gaussian component of the summed fit of the distributions in C and D, and 
the percentage of the pixels that comprise each component.
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high-order mGAT1 oligomers represented by the inter-
mediate-amplitude component of the NFRET distribu-
tions (Raicu et al., 2009).
Trafficking and oligomerization motifs in mGAT1  
and similar transporters
Appropriate mGAT1 plasma membrane expression re-
quires a class II PDZ–interacting motif at the terminal 
residues of mGAT1 (Chiu et al., 2002; Farhan et al., 
2004). In mGAT1, this motif mediates interactions with 
the exocyst complex (Farhan et al., 2004) and in tether-
ing GAT1 to the actin cytoskeleton (Imoukhuede et al., 
2009). The present data show that the primary sequence 
of that motif can be either the native -AYI from GAT1 
or another class II motif from a different molecule   
(-YKV-CO2
). Both motifs have experimentally determined 
interaction partners (Brückner et al., 1999; Lin et al., 
1999; McHugh et al., 2004; Imoukhuede et al., 2009). 
However, the identity and combination of the hydro-
phobic residues at P(0) and P(2) is important (Harris 
and Lim, 2001; Sheng and Sala, 2001). The terminal   
-YKI-CO2
 sequence of mGAT10XFP is not present at the 
C terminus of any known membrane protein and evi-
dently is poorly used by PDZ domain–containing pro-
teins in N2a cells or in vivo (Chiu et al., 2002). The 
sequence of the C-terminal type II PDZ–interacting mo-
tif and its interacting partners are therefore critical in 
the events that lead to the emergence of the third high-
amplitude component of NFRET in the cell periphery.
Besides  the  terminal  type  II  PDZ–interacting  se-
quence, apparently no other motifs influence traffick-
ing within the sequence between the P(3) and P(28) 
positions in the GAT1 C terminus. These findings cor-
roborate  previous  studies  of  truncation  mutations  in 
neuronal  SLC6  transporter  trafficking  (Torres  et  al., 
2003; Farhan et al., 2004). However, a region in the   
C termini of SLC6 transporters corresponding to the 
P(28) through P(44) residues of mGAT1 controls 
constitutive export of transporter from the ER (Farhan 
et al., 2004, 2007, 2008) and both constitutive and regu-
lated endocytosis (Holton et al., 2005; Boudanova et al., 
2008). mGAT1XFP45 possesses two copies of this region 
(Fig. 2), but its uptake deficit (Fig. 4 A) is caused pre-
dominantly by poor oligomerization (Figs. 6 D and 9), 
rather than by the introduction of additional endocytic 
or exocytotic motifs. Nonetheless, mGAT1
565XFP
566CT 
showed extensive oligomerization (Fig. 10, A–D) but poor 
trafficking to the plasma membrane (Fig. 5 B), presum-
ably because placing the fluorophore between residues 
R565 (P(33)) and L566 (P(32)) (Fig. 2) inhibited 
interaction with the COPII coat (Farhan et al., 2007; 
Reiterer et al., 2008). Moreover, in mGAT1
565XFP
566CT, the 
XFP is adjacent to the 
562LKQR
565 residues (analogous to 
587FREK
590 in hDAT) that slow the basal rate of transporter 
internalization (Boudanova et al., 2008); this may result 
in faster endocytosis for this construct relative to wild-type 
mGAT1XFP8 oligomers internalized during the early min-
utes of the latrunculin B incubation could possibly get 
trapped inside the cell (Taunton et al., 2000; Gauthier 
et al., 2007; Morel et al., 2009). Nonetheless, exocyst-
driven  plasma  membrane  GAT1  insertion  requires  the 
transporter’s PDZ-interacting domain (Farhan et al., 2004). 
Most proteins that form the exocyst complex are loaded 
onto vesicles in the trans-Golgi region (Munro, 2004), and 
their trafficking to the site of exocytosis requires an intact 
actin cytoskeleton (Boyd et al., 2004). In latrunculin B–
treated N2a cells, mGAT1XFP8 oligomers presumably as-
sociate normally via their PDZ-interaction domains, with 
the vesicle-associated exocyst complex in the vicinity of the 
trans-Golgi.  However,  cytoskeletal  disruption  inhibits 
transport of the vesicles and their cargo away from this lo-
cation, resulting in a third high-amplitude NFRET compo-
nent being recorded in the perinuclear ROI. In contrast, 
despite possessing a wild-type PDZ-interaction domain, 
the  efficiently  oligomerized  but  intracellularly  retained 
mGAT1
565XFP
566CT constructs present only two perinu-
clear NFRET components because the location of the flu-
orophore prevents the normal interaction with the COPII 
coat complex (Farhan et al., 2007). This mutation domi-
nates over the PDZ interactions: transporter complexes 
cannot exit from the ER (Farhan et al., 2004) to the trans-
Golgi, where the first exocyst/PDZ-interacting domain in-
teractions occur.
Pixel-by-pixel resolution in NFRET
Ultimately, one would like to measure the assembly of 
membrane  proteins  at  single-molecule  resolution  in 
each cellular compartment. At present, this is possible 
only at the plasma membrane using total internal re-
flection fluorescence in FRET mode (Riven et al., 2006; 
Bal et al., 2008a,b), although superresolution micros-
copy may enable further progress (Hess et al., 2007; 
Manley et al., 2008; Tokunaga et al., 2008). We have 
therefore resorted to measurements on single pixels, 
69-nm square. We estimate that each pixel represents 
10–150 mGAT1 molecules, based on comparisons with 
known samples that we have imaged at single-molecule 
resolution under comparable conditions (Chiu et al., 
2001). A pixel’s NFRET amplitude is determined by the 
concentration of each FRET-yielding oligomer type in 
that pixel (Corry et al., 2005b), not by the concentra-
tion of fluorophores. Methods to measure FRET in 
biological samples are continually evolving. Recently, 
investigators  have  minimized  spurious  FRET  by  judi-
ciously selecting the fluorophores by using appropriate 
instrumentation, and by controlling optical variations 
during both an individual experiment and the entire 
investigation (Raicu et al., 2009; Tadross et al., 2009). 
Combining these enhancements with the method pre-
sented in this paper will further increase the resolution 
and reliability of confocal FRET data. We hope eventu-
ally to determine the supramolecular geometry of the   Moss et al. 515
prevent mGAT10GFP from recapitulating its in vivo behav-
ior when expressed in HEK 293T cells. The first is overex-
pression caused by the presence of the simian virus 40 
(SV40) large T antigen in HEK 293T cells, which allows for 
episomal replication of transfected plasmids, such as the 
pcDNA3.1(+) used in this study, that contain the SV40 
origin of replication. Consistent with this hypothesis, 
[
3H]GABA uptake was maximal in HEK 293T cells trans-
fected with only 50–100 ng mGAT1 plasmid, yet submaxi-
mal for 500 ng of plasmid in N2a cells (which lack the 
SV40 T antigen) (Fig. 1). Furthermore, the total fluores-
cence of mGAT10GFP was almost fivefold greater when 
expressed in HEK 293T cells compared with N2a cells 
(Fig. 1, D–F). We suspect that overexpression of mGAT1 in 
HEK 293T cells exceeds the capacity of one or more cellu-
lar trafficking mechanisms, so that the cell cannot dynami-
cally regulate transporter number at the cell surface.
A second possible explanation for the difference in traf-
ficking between HEK 293T cells and mouse neurons is 
that HEK 293T cells do not express the necessary collec-
tion of associating proteins to regulate GAT1 trafficking 
appropriately. For example, protein interacting with C 
kinase 1 (PICK1), a PDZ protein involved in GAT1 plasma 
membrane trafficking, is expressed in N2a cells but hardly 
detectable in HEK 293 cells (Bjerggaard et al., 2004). How-
ever, HEK 293T cells appear to process and traffic mGAT-
10GFP like wild-type mGAT1, suggesting that this cell type 
does not rely on PDZ interactions to deliver GAT1 to or 
stabilize its presence at the plasma membrane. Rather, 
HEK 293T cells may use distinct pathways for these pro-
cesses. In fact, hNET mutants with truncated C termini 
function like wild-type transporter in HEK 293 cells (from 
which HEK 293T is derived), although in many other cell 
lines, truncation mutants exhibit reduced substrate uptake 
(Bauman and Blakely, 2002).
HEK 293T cells were valuable for pioneering heterolo-
gous expression studies of excitability proteins (Lester, 
1988) and still serve well when one desires sheer quantity 
rather than faithful processing, assembly, sorting, regula-
tion, and targeting. However, our studies show that N2a 
cells more closely resemble the native neuronal environ-
ment of mGAT1. We developed a transfection protocol 
and uptake assay in the N2a cell line that remained in the 
linear range with respect to protein expression level, sub-
strate concentration, and assay duration. We chose to work 
with  the  N2a  cell  line  because  its  provenance  closely 
matches that of the mGAT1 protein that we were studying: 
mouse and neuronal. We cannot claim perfect fidelity, but 
several influences on expression, oligomerization, and traf-
ficking are readily reflected by changed function under 
these assay conditions.
Conclusion
We have determined standardized designs for fluores-
cent transporter fusions, applied a sensitized emission 
pixel-by-pixel NFRET analysis method, and measured 
GAT1. The trafficking deficit in mGAT1
565XFP
566CT also 
supports earlier findings that mutations of this region 
dominate over the presence of a class II PDZ–interacting 
motif at the distal C terminus (Farhan et al., 2004).
For mGAT1
570XFP
571CT, we suggest that moving the 
fluorophore more distal in the C terminus partially re-
lieved the impaired trafficking of the transporters because 
the 
565RL
566 is preserved, allowing interaction with the 
COPII machinery, and the XFP is further from 
562LKQR
565, 
slowing  the  basal  internalization  relative  to  mGAT1
565 
XFP
566CT.  Nevertheless,  the  functional  expression  of 
mGAT1
570XFP
571CT at the plasma membrane is probably 
hampered because the fluorophore is adjacent to, and 
may sterically interfere with, the 
568VMI
570 motif, which 
specifies export from the ER–Golgi intermediate com-
partment (Farhan et al., 2008).
Almost  wild-type–like  function  (similar  Km  and  78% 
Vmax) and strong NFRET in the periphery were achieved 
in the mGAT1
577XFP
578CT design, in which the XFP was 
inserted 6 residues after the 10-residue region, rich in 
regulatory information for transporter trafficking (Figs. 2, 
5, B and C, and 10, and Table I) (Farhan et al., 2004, 
2007, 2008; Holton et al., 2005; Boudanova et al., 2008). 
We will continue to investigate the endocytosis and exocy-
tosis of these constructs. The functional (Fig. 5, B and C) 
and NFRET (Fig. 10) data suggest that both mGAT1XFP8 
and mGAT1
577XFP
578CT assemble well as mature trans-
porters, and the latter construct has a small deficit in the 
number of transporters finally inserted into the plasma 
membrane.  mGAT1
577XFP
578CT  and  mGAT1XFP8  dis-
played  similar  proportions  of  low-,  intermediate-,  and 
high-amplitude components for peripheral ROI NFRET 
distributions, and this may imply similar oligomerization 
and interaction states for the constructs. Of these two 
pairs, the mGAT1
577XFP
578CT pair can indicate mGAT1 
assembly more sensitively because the apparently nearby 
fluorophores have robust FRET.
Value of a linear, responsive cellular assay
Various cell lines and transient transfection techniques 
have been applied to investigate the oligomerization and 
trafficking of SLC6 transporters (Melikian and Buckley, 
1999; Schmid et al., 2001; Whitworth and Quick, 2001; 
Chiu et al., 2002; Torres et al., 2003; Bjerggaard et al., 2004; 
Farhan et al., 2004, 2007; Just et al., 2004; Korkhov et al., 
2004; Holton et al., 2005; Mazei-Robison and Blakely, 2005; 
Soragna et al., 2005; Bartholomäus et al., 2008). In gene 
transfer experiments, quantitative analysis of protein func-
tion can be vitiated by several mechanisms that cause a 
“ceiling,” “maximum,” “limit,” “plateau,” “leveling off,” or 
“saturation” of measured uptake. This study’s data, as well 
as our laboratory’s previously reported findings, show that 
when mGAT10GFP is transiently expressed in the widely 
used HEK 293T cell line, its [
3H]GABA uptake appears 
normal despite its significant trafficking deficits in vivo 
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also considered because mGAT1 molecules function as 
monomers; therefore, an mGAT1 oligomer might not 
display the approximate fourfold radial symmetry that 
constrains voltage-gated channels (Scholze et al., 2002; 
Yamashita et al., 2005; Zhang and Rudnick, 2006).   
Fig. 18 D shows a model of the apparent FRET efficiencies   
that would arise from populations of mGAT1 dimers, 
square  tetramers,  or  rhomboid  tetramers  for  various 
distances between fluorophores. To set the initial value 
for the closest distance between protomers r1, we used 
the LeuTAa structure (PDB entry 2A65A; Yamashita   
et al., 2005). We assumed that the fluorophores in the 
mGAT1 C terminus hang directly below the substrate 
molecule  in  the  protomer  core.  We  determined  the 
proportional values for r2–4 when we varied r1 (Fig. 18, 
A–C). The dimensions of the XFP barrel limit the small-
est measurable distance for side-by-side chromophores 
in  an  oligomerized  membrane  protein  to  r1  =  24  Å 
(Ormö et al., 1996), and we assumed a largest value of 
r1 = 100 Å. The FRET efficiency for each tetramer con-
figuration for each r1 was determined and multiplied by 
the probability of its occurrence to determine the ap-
parent FRET, Eapp (Corry et al., 2005a). We also assumed 
that energy transfer always occurs in all possible FRET-
yielding configurations (i.e., fluorophore bleaching or 
blinking was not factored into the calculations), with 
exactly  equal  representation  of  donor-  and  acceptor-
tagged protomers in all compartments and equally effi-
cient assembly of dimers and high-order oligomers.
The calculations show that, relative to Eapp from a 
dimer, a square tetramer and a rhomboid tetramer have 
1.33- to 1.96-fold and 1.54- to 2.87-fold higher FRET, re-
spectively, as r1 varies. For the majority of the constructs 
examined in this paper, the mean NFRET amplitude of 
the second Gaussian fit component was between 1.6- 
and 2.6-fold greater than for the lowest-amplitude first 
component.
We discuss the width of each component to the Gauss-
ian fits to the mGAT1 NFRET distributions. Consider 
the simple example of a single pixel in which the only 
oligomer type possible is a dimer. The NFRET amp-
litude from that pixel is determined by the number of 
dimers that possess both a donor- and acceptor-tagged 
protomer, but the signal from these oligomers is nor-
malized to the square root of the product of the pixel’s 
donor and acceptor fluorophore intensities. Donor-
donor dimers, acceptor-acceptor dimers, and non-oligo-
merized  monomers  can  also  exist  in  the  pixel. 
Furthermore, immature, bleached, or misfolded XFP 
moieties may exist, all reducing the measured NFRET 
from donor-acceptor dimers (Fig. 18 A). If all pixels in 
an ROI contain only dimers, the fit to the NFRET am-
plitude distribution has a width determined by the vari-
ation in the number of FRET-yielding dimers relative 
to the total fluorophore concentration per pixel in the 
ROI. Some of these statistical considerations generate a 
the radial distribution of NFRET amplitudes to investi-
gate the basic and high-order oligomerization and pe-
ripheral interactions of the mGAT1 transporter. Each of 
these important events is reported as a Gaussian compo-
nent  of  the  all-pixel  NFRET  amplitude  distribution. 
These techniques might also reveal the basic and high-
order oligomerization of other SLC6 transporter mem-
bers (Kilic and Rudnick, 2000; Hastrup et al., 2003; Just 
et al., 2004; Bartholomäus et al., 2008) and other multi-
subunit plasma membrane proteins (Raicu et al., 2009; 
Son et al., 2009). Future investigations will study the dy-
namic changes in the interactions of transporters with 
regulatory and scaffolding partners in various subcellu-
lar compartments, and will examine critical events in 
transporter modulation, such as the recently reported 
substrate-mediated  dissociation  of  transporter  oligo-
mers (Chen and Reith, 2008).
A p p E N D I x :   
F R E T   F O R   D I M E R S   A N D   T E T R A M E R S
We assume that the fluorescent mGAT1 constructs with 
the most wild-type function most accurately report the 
normal oligomerization properties of mGAT1 via FRET. 
The lowest-order oligomer is a dimer. If we assume that 
CFP- and YFP-tagged fluorescent mGAT1 protomers are 
synthesized and fold equally efficiently, in a cell trans-
fected by equimolar amounts of the donor and accep-
tor cDNAs, a binomial distribution of donor-donor–, 
donor-acceptor–, and acceptor-acceptor–tagged dimers 
will exist (Fig. 18 A). Only 50% of the total oligomer 
population, the donor-acceptor dimers, will contribute 
to the NFRET amplitude. This means that the experi-
mentally  measured  NFRET  amplitude  for  a  specific 
pixel is not the true “pair-wise” FRET data of a single 
CFP-YFP pair, but is the “apparent” FRET of a specific 
concentration of the FRET-yielding dimers, mixed with 
non-FRET productive dimers, and in some organelles 
donor or acceptor monomers (Raicu, 2007). In oligo-
mers larger than dimers, there is more than one path-
way for nonradiative energy transfer (Fig. 18, B and C). 
The apparent FRET in each pixel is influenced by:
(a) The number of donor-acceptor pair radii in the 
oligomers (e.g., two possible FRET radii exist in a square 
tetramer; r and r 2 .
(b) The stoichiometry of the donor and acceptor flu-
orophores within each oligomer.
(c) The relative concentration of each oligomer stoi-
chiometry type.
(d) The proportions of dimers versus higher-order 
oligomers that exist in the pixel.
We considered two possible forms of such an mGAT1 
tetramer. The square tetramer would resemble the ar-
rangement of subunits in voltage-gated potassium chan-
nels (Kerschensteiner et al., 2005; Miranda et al., 2008) 
(Fig. 18 B). A rhomboid organization (Fig. 18 C) was   Moss et al. 517
distribution is fit by a single Gaussian of average amp-
litude greater than that for the dimer case; however, the 
full width at half-maximum exceeds that from the ROI 
containing only dimers. We observed throughout this 
work that the full width at half-maximum of the first 
low-amplitude NFRET component was less than for the 
second medium-amplitude component (Figs. 8 H, 10,   
D and H, 11 D, and 16 D). Given the presence of nega-
tive NFRET amplitudes, we think it unwise to convert 
the full width at half-maximum values to coefficients 
of variation.
Pixels are 69 nm
2, but a pixel’s optical signal also con-
tains X, Y, and Z contributions from nearby regions, as 
appropriate to the microscope’s point-spread function, 
binomial distribution; but given the additional effects, 
and the transformation from nF to NFRET, we assume a 
Gaussian distribution.
Now consider a pixel containing only mGAT1 tetra-
mers. There are two major sources of variation in the 
NFRET amplitude: (1) the proportion of the total fluo-
rophore concentration in the pixel that assembles into 
FRET-yielding tetramers, and (2) the relative contribu-
tions of each FRET-yielding donor and acceptor fluoro-
phore stoichiometry in the pixel (Fig. 18, B and C). 
Tetramers have more sources of variation than dimers. 
Therefore, for an ROI whose pixels contain only tetra-
mers, and at levels of donor and acceptor fluorophores 
equal to that of a pure dimer population, the NFRET 
Figure  18.  Theory  of  FRET 
from three oligomer types with 
several  fluorophore  stoichiom-
etries.  (A)  XFP-tagged  mGAT1 
protomers can assemble in three 
possible fluorophore stoichiom-
etries. (B) Square tetramers can 
have  six  possible  fluorophore 
configurations.  (C)  There  are 
nine possible configurations of a 
rhomboid  tetramer.  Nomencla-
ture for panels A–C: D, donor; A, 
acceptor; ExD:yA, FRET efficiency 
for  each  configuration  where   
x and y represent the number of 
donor or acceptor fluorophores, 
respectively; R0, the Förster dis-
tance for a CFP-YFP pair; r1, the 
pair-wise FRET radius in the ba-
sic mGAT1 dimer; r2-r4, the three 
other pair-wise FRET radii pre-
sent in either square tetramers 
or rhomboid tetramers. (D) Plot 
of  the  apparent  FRET  (EApp) 
modeled  for  mGAT1  dimers, 
square  tetramers,  or  rhomboid 
tetramers with changing r1, the 
pair-wise FRET radius in the ba-
sic mGAT1 dimer.518 NFRET resolves GAT1 oligomerization state and anchoring
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